This is a Validated Antibody Database (VAD) review about mouse Cd44, based on 760 published articles (read how Labome selects the articles), using Cd44 antibody in all methods. It is aimed to help Labome visitors find the most suited Cd44 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cd44 synonym: AU023126; AW121933; AW146109; HERMES; Ly-24; Pgp-1

Knockout validation
Developmental Studies Hybridoma Bank
rat monoclonal (5D2-27)
  • western blot knockout validation; mouse; fig 2b
Developmental Studies Hybridoma Bank Cd44 antibody (DSHB, 5D2-27) was used in western blot knockout validation on mouse samples (fig 2b). Cell (2018) ncbi
BioLegend
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig s7-1b
BioLegend Cd44 antibody (Biolegend, 103044) was used in flow cytometry on mouse samples at 1:100 (fig s7-1b). elife (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Exp Med (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4f). Front Cell Infect Microbiol (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples (fig 2a). Sci Adv (2022) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4e
BioLegend Cd44 antibody (Biolegend, IM7) was used in immunohistochemistry - paraffin section on mouse samples (fig 4e). Glia (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend Cd44 antibody (Biolegend, 103029) was used in flow cytometry on mouse samples (fig 4c). iScience (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6a). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; loading ...
BioLegend Cd44 antibody (BioLegend, 103011) was used in flow cytometry on human samples at 1:200. Nat Commun (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3a, s3c
BioLegend Cd44 antibody (Biolegend, 103047) was used in flow cytometry on mouse samples (fig s3a, s3c). PLoS Pathog (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 1g
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 1g). Nat Commun (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c, 3d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2c, 3d). Int J Mol Sci (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 3d
BioLegend Cd44 antibody (BioLegend, 103057) was used in flow cytometry on mouse samples at 1:100 (fig 3d). Cell Rep (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend Cd44 antibody (Biolegend, 103028) was used in flow cytometry on mouse samples (fig 5f). Oncoimmunology (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Nature (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Cd44 antibody (BioLegend, 103024) was used in flow cytometry on mouse samples (fig 3c). Cells (2022) ncbi
rat monoclonal (IM7)
  • mass cytometry; human; loading ...; fig 4a
BioLegend Cd44 antibody (Biolegend, 103051) was used in mass cytometry on human samples (fig 4a). Cell Rep (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 7g, 7j
BioLegend Cd44 antibody (BioLegend, 103016) was used in flow cytometry on mouse samples at 1:200 (fig 7g, 7j). elife (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 4e
BioLegend Cd44 antibody (BioLegend, 103026) was used in flow cytometry on human samples (fig 4e). J Clin Invest (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2b). JCI Insight (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a, s8g
BioLegend Cd44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples (fig 5a, s8g). J Clin Invest (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s9e
BioLegend Cd44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples (fig s9e). Sci Immunol (2021) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; loading ...; fig 2f
BioLegend Cd44 antibody (BioLegend, 103011) was used in immunohistochemistry on mouse samples (fig 2f). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 1c). J Immunother Cancer (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Commun Biol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 3c, s4b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 3c, s4b). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . Am J Physiol Endocrinol Metab (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
BioLegend Cd44 antibody (Biolegend, 103011) was used in flow cytometry on mouse samples at 1:200 (fig 1c). Aging Cell (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend Cd44 antibody (BioLegend, 103 028) was used in flow cytometry on mouse samples . Adv Sci (Weinh) (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend Cd44 antibody (Biolegend, 103002) was used in flow cytometry on mouse samples . Cancer Cell (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend Cd44 antibody (BioLegend, 103040) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig s5-1g
BioLegend Cd44 antibody (BioLegend, 103028) was used in flow cytometry on mouse samples at 1:100 (fig s5-1g). elife (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig s22a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig s22a). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1b
BioLegend Cd44 antibody (Biolegend, 103011) was used in flow cytometry on mouse samples (fig s1b). Transl Oncol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5d). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2g
BioLegend Cd44 antibody (BioLegend, 103047) was used in flow cytometry on mouse samples at 1:100 (fig 2g). elife (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd44 antibody (BioLegend, 103047) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 1b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig 1b). Sci Rep (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1a). Front Immunol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 1b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Front Immunol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend Cd44 antibody (Biolegend, 103049) was used in flow cytometry on mouse samples . Cell (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2c
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2c). J Immunother Cancer (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5c). J Autoimmun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig s4c
BioLegend Cd44 antibody (Biolegend, 103018) was used in flow cytometry on mouse samples at 1:200 (fig s4c). Front Cell Dev Biol (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig s5b
  • flow cytometry; mouse; 1:1000; loading ...; fig s4c
BioLegend Cd44 antibody (BioLegend, 103012) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s5b) and in flow cytometry on mouse samples at 1:1000 (fig s4c). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 3c). Science (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Cd44 antibody (BioLegend, 103010) was used in flow cytometry on mouse samples at 1:100. Nature (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4l
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4l). Aging Cell (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2f
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2f). Antioxidants (Basel) (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 1:200; loading ...
BioLegend Cd44 antibody (Biolegend, 103006) was used in immunohistochemistry on mouse samples at 1:200. elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; loading ...; fig 3a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on human samples at 1:200 (fig 3a). Cancers (Basel) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Cd44 antibody (BioLegend, 103044) was used in flow cytometry on mouse samples (fig s2a). Cell (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5c). Sci Adv (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 1f
BioLegend Cd44 antibody (BioLegend, 103047) was used in flow cytometry on mouse samples at 1:800 (fig 1f). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on human samples . Theranostics (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; loading ...; fig s2c
BioLegend Cd44 antibody (Biolegend, 103021) was used in flow cytometry on human samples at 1:200 (fig s2c). Cancers (Basel) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. J Allergy Clin Immunol (2021) ncbi
rat monoclonal (IM7)
BioLegend Cd44 antibody (BioLegend, IM7) was used . Nature (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5d). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . BMC Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2s1
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 2s1). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s18
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s18). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
BioLegend Cd44 antibody (Biolegend, IM7) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). Sci Rep (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples (fig 1c). Cell Rep (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Cd44 antibody (Biolegend, 103016) was used in flow cytometry on mouse samples (fig 3c). elife (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 2f
BioLegend Cd44 antibody (Biolegend, 103059) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 2f). elife (2020) ncbi
mouse monoclonal (OX-49)
  • flow cytometry; rat; loading ...; fig 2
BioLegend Cd44 antibody (Biolegend, 203906) was used in flow cytometry on rat samples (fig 2). Exp Ther Med (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e, 1j
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1e, 1j). Sci Adv (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1a). Aging (Albany NY) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2s1b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2s1b). elife (2020) ncbi
rat monoclonal (IM7)
  • mass cytometry; mouse; 1:800; loading ...; fig s32a, s32c
BioLegend Cd44 antibody (Biolegend, 103002) was used in mass cytometry on mouse samples at 1:800 (fig s32a, s32c). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s9e
BioLegend Cd44 antibody (Biolegend, 103005) was used in flow cytometry on mouse samples (fig s9e). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5a). Sci Adv (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s5b). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e4d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig e4d). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend Cd44 antibody (Biolegend, 103028) was used in flow cytometry on mouse samples (fig s1c). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
BioLegend Cd44 antibody (Biolegend, 103015) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1h
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1h). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Aging (Albany NY) (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a, 5a, 6a, s4b
BioLegend Cd44 antibody (BioLegend, 103059) was used in flow cytometry on mouse samples (fig 3a, 5a, 6a, s4b). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; loading ...; fig 2a
BioLegend Cd44 antibody (Biolegend, IM7) was used in immunocytochemistry on mouse samples (fig 2a). Biol Sex Differ (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend Cd44 antibody (Biolegend, 103008) was used in flow cytometry on mouse samples (fig s1b). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend Cd44 antibody (BioLegend, 103051) was used in flow cytometry on mouse samples (fig s1c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
BioLegend Cd44 antibody (Biolegend, 103016) was used in flow cytometry on mouse samples (fig 5a). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4f
BioLegend Cd44 antibody (Biolegend, 103031) was used in flow cytometry on mouse samples (fig s4f). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s4b). JCI Insight (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4d
BioLegend Cd44 antibody (Biolegend, 103028) was used in flow cytometry on mouse samples (fig s4d). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s6a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s6a). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 2a). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 4a
BioLegend Cd44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples at 1:200 (fig 4a). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2e). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend Cd44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples (fig s1e). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend Cd44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples (fig s1e). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 1bc
BioLegend Cd44 antibody (BioLegend, 103021) was used in flow cytometry on mouse samples at 1:100 (fig 1bc). Exp Ther Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend Cd44 antibody (Biolegend, 103008) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend Cd44 antibody (Biolegend, 103057) was used in flow cytometry on mouse samples (fig 2h). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Cd44 antibody (BioLegend, 103028) was used in flow cytometry on mouse samples (fig s2b). Immunity (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1d
BioLegend Cd44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples at 1:200 (fig 1d). elife (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend Cd44 antibody (BioLegend, 103054) was used in flow cytometry on mouse samples (fig s8b). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend Cd44 antibody (Biolegend, 103039) was used in flow cytometry on mouse samples (fig 5c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8c). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1f). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e1e
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig e1e). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Cd44 antibody (Biolegend, 103043) was used in flow cytometry on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Cd44 antibody (Biolegend, 103047) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s4a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5d). JCI Insight (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c
BioLegend Cd44 antibody (Biolegend, 103012) was used in flow cytometry on mouse samples at 1:400 (fig 1c). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend Cd44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples (fig 7a). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b, 5c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2b, 5c). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 5d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 5d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). PLoS ONE (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1c). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s19
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s19). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e2e
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig e2e). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3f
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3f). EMBO J (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend Cd44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2h). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd44 antibody (BioLegend, 103020) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
  • immunocytochemistry; mouse; loading ...; fig 1c
BioLegend Cd44 antibody (Biolegend, 103035) was used in flow cytometry on mouse samples (fig 1b) and in immunocytochemistry on mouse samples (fig 1c). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1h
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1h). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • immunoprecipitation; human; loading ...; fig sf1
  • immunocytochemistry; human; 1:250; loading ...; fig sf2
BioLegend Cd44 antibody (Biolegend, IM-7) was used in immunoprecipitation on human samples (fig sf1) and in immunocytochemistry on human samples at 1:250 (fig sf2). Oncotarget (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s1a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig s1a). Nat Commun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, BioLegend Cd44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
In order to evaluate mouse models of hepacivirus infection, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s8c). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2k
In order to investigate the role of dopamine in B cell maturation in germinal centres, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2k). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
In order to characterize the regulatory T cells expressing T-bet transcriptional factor, BioLegend Cd44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples (fig 3f). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s3b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s3b). Nat Commun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1c
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3a). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BioLegend Cd44 antibody (BioLegend, 103008) was used in flow cytometry on human samples (fig 2b). Oncogenesis (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to find factors that regulate follicular T helper cell migration and function, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5b). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3c). Nat Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend Cd44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; loading ...; fig 1e
  • flow cytometry; human; loading ...; fig 1f
In order to compare human and feline adipose-derived mesenchymal stem cells, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on cat samples (fig 1e) and in flow cytometry on human samples (fig 1f). Stem Cell Res Ther (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6b). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
rat monoclonal (IM7)
In order to investigate DNA repair in CD44+/CD24- cells, BioLegend Cd44 antibody (BioLegend, 103029) was used . elife (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Mucosal Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Oncotarget (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to report that differentiation and self-renewal arise as opposing outcomes of sibling CD4 positive T cells during challenge with influenza, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, BioLegend Cd44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Infect Immun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 6c). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6f
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4
In order to characterize systemic antimicrobial CD4 positive T cell reactivity, BioLegend Cd44 antibody (Biolegend, Im7) was used in flow cytometry on mouse samples (fig s4). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 5e
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:800 (fig 5e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 5
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
BioLegend Cd44 antibody (BioLegend, 103022) was used . Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3
BioLegend Cd44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; loading ...; fig 3g
BioLegend Cd44 antibody (BioLegend, IM7) was used in immunocytochemistry on human samples (fig 3g). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend Cd44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig s1). Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2
BioLegend Cd44 antibody (Biolegend, 103015) was used in flow cytometry on human samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig S1
In order to study the effect of IL-10 signaling in infectious neurological diseases, BioLegend Cd44 antibody (BioLegend, clone IM7) was used in flow cytometry on mouse samples (fig S1). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3d
In order to test if a combination of LYN and Aire defects result in organ-specific autoimmunity, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, BioLegend Cd44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 4
BioLegend Cd44 antibody (Biolegend, 103015) was used in immunocytochemistry on human samples (fig 4). Biol Open (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 4
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 4). J Virol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 4
BioLegend Cd44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples at 1:100 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 4f
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 4f). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; loading ...; fig 1a
  • immunohistochemistry; human; loading ...; fig 1a
BioLegend Cd44 antibody (Biolegend, IM7) was used in immunohistochemistry on mouse samples (fig 1a) and in immunohistochemistry on human samples (fig 1a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
In order to study promotion of host immunity and protection against IL-12/23p40-dependent lung injury during hookworm infection by myeloid-restricted AMPK-alpha1, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3e
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3c
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5f
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Gastroenterology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1b
BioLegend Cd44 antibody (Biolegend, 103029) was used in flow cytometry on human samples (fig 1b). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6s
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6s). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend Cd44 antibody (Biolegend, 1M7) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2f
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend Cd44 antibody (BioLegend, 103016) was used in flow cytometry on mouse samples at 1:400 (fig 2f). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Int J Oncol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend Cd44 antibody (Biolegend, 103026) was used in flow cytometry on mouse samples (fig 6). Nature (2015) ncbi
rat monoclonal (IM7)
BioLegend Cd44 antibody (Biolegend, 103030) was used . Sci Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; fig 2
In order to examine the effect of fresh, autologous, adipose-derived mesenchymal stem cells on feline chronic gingivostomatitis, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on cat samples (fig 2). Stem Cells Transl Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend Cd44 antibody (BioLegend, IMF7) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1d). Arthritis Rheumatol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s7
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s7). elife (2015) ncbi
rat monoclonal (IM7)
BioLegend Cd44 antibody (BioLegend, 103021) was used . Mol Med Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Cancer Res (2015) ncbi
mouse monoclonal (OX-49)
  • flow cytometry; rat; fig s1
BioLegend Cd44 antibody (Biolegend, 203906) was used in flow cytometry on rat samples (fig s1). Cell Tissue Res (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3a
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (IM7)
BioLegend Cd44 antibody (Biolegend, IM7) was used . Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s6
BioLegend Cd44 antibody (Biolegend, 103024) was used in flow cytometry on mouse samples (fig s6). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 1
BioLegend Cd44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s2). Brain (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
BioLegend Cd44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend Cd44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
mouse monoclonal (OX-49)
  • flow cytometry; rat; fig 2
BioLegend Cd44 antibody (BioLegend, OX-49) was used in flow cytometry on rat samples (fig 2). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to examine the role of interleukin-4 in relation to eomesodermin within CD8+ T cells, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
  • immunohistochemistry; human; fig 2
In order to study reprogramming of cells toward a metastatic-like state by p53 psi, a transcriptionally inactive p53 isoform, BioLegend Cd44 antibody (Biolegend, IM-7) was used in flow cytometry on mouse samples (fig 1) and in immunohistochemistry on human samples (fig 2). Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate how Fbw7-mediated GATA3 regulation and CDK2-mediated phosphorylation of Cdc4 phosphodegron regulate differentiation of T-cell lineages, BioLegend Cd44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend Cd44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples . Ann Neurol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
BioLegend Cd44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 4). Vaccine (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:200; loading ...; fig st13
BioLegend Cd44 antibody (Biolengend, IM7) was used in immunocytochemistry on human samples at 1:200 (fig st13). Nat Cell Biol (2014) ncbi
rat monoclonal (IM7)
In order to evaluate a coculture system for in vitro colonoid formation, BioLegend Cd44 antibody (Biolegend, 103001) was used . Am J Physiol Gastrointest Liver Physiol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend Cd44 antibody (BioLegend, 103009) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend Cd44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cell Cycle (2012) ncbi
Invitrogen
rat monoclonal (IM7)
  • immunocytochemistry; mouse; 1:200; loading ...; fig s3e
Invitrogen Cd44 antibody (Thermo Fisher, 14-0441-82) was used in immunocytochemistry on mouse samples at 1:200 (fig s3e). Nat Commun (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1a
Invitrogen Cd44 antibody (eBioscience, 12-0441-82) was used in flow cytometry on human samples (fig 1a). World J Stem Cells (2022) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; loading ...; fig 3b, 3c
Invitrogen Cd44 antibody (eBioscience, 17-0441-82) was used in immunocytochemistry on human samples (fig 3b, 3c). JBMR Plus (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Cd44 antibody (eBioscience, 45-0441-82) was used in flow cytometry on mouse samples (fig 1f). Cell Rep (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 1e
Invitrogen Cd44 antibody (eBioscience, 17-0441-82) was used in flow cytometry on mouse samples at 1:100 (fig 1e). Stem Cell Res Ther (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e, s3
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e, s3). Int J Mol Sci (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2n
Invitrogen Cd44 antibody (eBioscience, 12-0441-83) was used in flow cytometry on mouse samples at 1:200 (fig 2n). Front Immunol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4b). J Immunother Cancer (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s5
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig s5). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4f). Acta Naturae (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen Cd44 antibody (eBioscience, 17-0441-83) was used in flow cytometry on mouse samples (fig 1e). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
Invitrogen Cd44 antibody (Thermofisher, IM7) was used in flow cytometry on mouse samples . Protein Cell (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 1a
Invitrogen Cd44 antibody (Thermo Fisher Scientific, 17-0441-83) was used in flow cytometry on mouse samples at 1:100 (fig 1a). elife (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s9b
Invitrogen Cd44 antibody (eBioscience, 61-0441-82) was used in flow cytometry on mouse samples (fig s9b). Sci Adv (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4b). elife (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 5e
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 5e). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen Cd44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; domestic horse; 1:100; loading ...; fig 1c
Invitrogen Cd44 antibody (Invitrogen, IM7) was used in flow cytometry on domestic horse samples at 1:100 (fig 1c). Animals (Basel) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 4b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on human samples (fig 4b). BMC Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2a
Invitrogen Cd44 antibody (eBioscience, 48-0441) was used in flow cytometry on mouse samples at 1:200 (fig 2a). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1s2a
Invitrogen Cd44 antibody (eBioscience, 25-0441-82) was used in flow cytometry on mouse samples at 1:200 (fig 1s2a). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Cd44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2019) ncbi
rat monoclonal (IM7)
Invitrogen Cd44 antibody (eBioscience, 12-0441-81) was used . Cell Rep (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig s1g
Invitrogen Cd44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples at 1:200 (fig s1g). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, s1c
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a, s1c). Sci Adv (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e10
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 7d
Invitrogen Cd44 antibody (Ebioscience, 48-0441-82) was used in flow cytometry on human samples (fig 7d). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:50; fig 3a, 3b
Invitrogen Cd44 antibody (eBioscience/Thermo, 17-0441-83) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s4b). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Cd44 antibody (Invitrogen, 45-0441-82) was used in flow cytometry on mouse samples (fig 3b). Int Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3e, s4b
Invitrogen Cd44 antibody (EBioscience, 61-0441-82) was used in flow cytometry on human samples (fig 3e, s4b). Breast Cancer Res (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Stem Cell Res Ther (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3k
Invitrogen Cd44 antibody (eBioscience, 17-0441-82) was used in flow cytometry on mouse samples at 1:200 (fig 3k). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2e
Invitrogen Cd44 antibody (eBioscience, 47-0441) was used in flow cytometry on mouse samples (fig s2e). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:100. Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, 8b
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a, 8b). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 6d
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 6d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 3s2a
Invitrogen Cd44 antibody (eBioscience, 48-0441-82) was used in flow cytometry on mouse samples at 1:300 (fig 3s2a). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig ex7g
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig ex7g). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd44 antibody (Thermo Fisher Scientific, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (1M7.8.1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
Invitrogen Cd44 antibody (Invitrogen, MA4405) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). Matrix Biol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Cd44 antibody (Thermo Fisher Scientific, IM-7) was used in flow cytometry on mouse samples (fig 2b). Eur J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 1d
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 1d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s6a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:600; loading ...; fig s12c
Invitrogen Cd44 antibody (Thermo Fisher Scientific, 48-0441-80) was used in flow cytometry on mouse samples at 1:600 (fig s12c). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Cd44 antibody (eBioscience, 17-0441-83) was used in flow cytometry on mouse samples (fig 4a). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen Cd44 antibody (eBioscience, 11-0441-82) was used in flow cytometry on human samples (fig 5a). Oncotarget (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Cell Death Dis (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e3c
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig e3c). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2j
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2j). Science (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd44 antibody (eBioscience, 17-0441-81) was used in flow cytometry on mouse samples (fig 1a). J Biol Chem (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7e
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
Invitrogen Cd44 antibody (Affymetrix/eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 3a). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3d
Invitrogen Cd44 antibody (eBiosciences, 25-0441-82) was used in flow cytometry on mouse samples (fig 3d). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2d
Invitrogen Cd44 antibody (eBiosciences, 17-0441-82) was used in flow cytometry on human samples (fig 2d). Oncogene (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4f). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd44 antibody (eBioscience, 12-0441) was used in flow cytometry on mouse samples (fig 1d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
  • immunocytochemistry; mouse; loading ...; fig s1b
Invitrogen Cd44 antibody (ThermoFisher Scientific, 17-0441) was used in flow cytometry on mouse samples (fig 1f) and in immunocytochemistry on mouse samples (fig s1b). Cell Stem Cell (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3g
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3g). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
Invitrogen Cd44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to investigate the role of protease-activated receptor 2 in lymphocyte development, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5b). Int J Biochem Cell Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, Invitrogen Cd44 antibody (eBioscience, 11-0441-81) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, Invitrogen Cd44 antibody (eBioscience, 17-0441) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to study the regulatory mechanism for the sex-dependent stroke mortality, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5c). Cell Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen Cd44 antibody (eBiosciences, 25-0441-81) was used in flow cytometry on mouse samples (fig 1e). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4a). Eur J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; fig s5e
In order to investigate how LACTB suppresses breast cancer cell growth, Invitrogen Cd44 antibody (eBioscience, 25-0441-81) was used in flow cytometry on human samples at 1:200 (fig s5e). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3d
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen Cd44 antibody (eBioscience, 12-0441-83) was used in flow cytometry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1d
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen Cd44 antibody (eBioscience, IM7) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Blood (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3e
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Invitrogen Cd44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on human samples (fig 3e). Mol Cancer (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to show that ABCA7 regulates natural killer T cell development in a cell-extrinsic manner, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1C
In order to evaluate the potential role of the attachment of myristic acid to the N-terminal glycine of proteins on the activation of gamma delta T cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1C). J Leukoc Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to determine that NKG2C/E identifies the CD4 T cell effector subset ThCTL that develop in the lung during influenza A virus infection in mice, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
  • immunocytochemistry; mouse; fig 2h
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a) and in immunocytochemistry on mouse samples (fig 2h). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s4a
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s4a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c
Invitrogen Cd44 antibody (Affymetrix eBioscience, 17-0441-81) was used in flow cytometry on mouse samples at 1:100 (fig 2c). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to discuss differences in eosinophil degranulation between humans and mice, Invitrogen Cd44 antibody (eBiosciences, M27) was used in flow cytometry on mouse samples (fig s1). Am J Respir Crit Care Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to assess the effect of adult Sertoli cell condition medium on the induction of germ cells from bone marrow mesenchymal stem cells, Invitrogen Cd44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples (fig 2). Iran J Basic Med Sci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:100; loading ...; fig 1C
In order to investigate the roles of CD44s and CD44v in the development of bone metastases, Invitrogen Cd44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on human samples at 1:100 (fig 1C). Oncol Lett (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to describe the microRNA regulatory network that is activated in macrophages during infection with Mycobacterium tuberculosis, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3e
In order to characterize side population T cells, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 3e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to elucidate how CD4 positive T cells help regulate blood pressure, Invitrogen Cd44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples (fig 1d). Nat Biotechnol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2c
In order to propose that loss of Llgl1 results in epidermal growth factor receptor mislocalization and leads to pre-neoplastic changes, Invitrogen Cd44 antibody (eBioscience, 17-0441) was used in flow cytometry on human samples (fig 2c). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; pigs ; fig 1b
  • immunocytochemistry; pigs ; 1:100; fig 1a
In order to assess the presence of vitamin D machinery on porcine adipose-derived MSCs, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on pigs samples (fig 1b) and in immunocytochemistry on pigs samples at 1:100 (fig 1a). Stem Cell Res Ther (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s4
In order to demonstrate that OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice, Invitrogen Cd44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples (fig s4). Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1
Invitrogen Cd44 antibody (eBioscience, 25-0441) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of galectin-3 in gastrointestinal cancer stem cells, Invitrogen Cd44 antibody (bd, 47044182) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6f
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen Cd44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6f). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Am J Pathol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:500; fig st1
Invitrogen Cd44 antibody (eBioscience, 25-0441) was used in flow cytometry on mouse samples at 1:500 (fig st1). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:50; fig 6
Invitrogen Cd44 antibody (eBioscience, 48-0441-82) was used in immunocytochemistry on human samples at 1:50 (fig 6). BMC Biol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 3
In order to assess targeting of tumor-initiating cells through down-regulation of stemness genes expression by cryptotanshinone, Invitrogen Cd44 antibody (eBioscience, 12-0441-82) was used in flow cytometry on human samples (fig 3). Oncol Lett (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 3d). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:500; loading ...; fig s10
In order to elucidate cellular mechanisms that regulate the formation of clusters of circulating tumor cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in immunocytochemistry on human samples at 1:500 (fig s10). J R Soc Interface (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to examine the effects of mesenchymal stromal cell-derived extracellular vesicles on bone marrow radiation damage, Invitrogen Cd44 antibody (eBioscience, 12-0441-82) was used in flow cytometry on mouse samples (fig s1). Leukemia (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, 25-0441) was used in flow cytometry on mouse samples . Biol Open (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2c
Invitrogen Cd44 antibody (eBiosciences, 17-0441-81) was used in flow cytometry on mouse samples (fig 2c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig cd44
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig cd44). Diabetes (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 7). elife (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 5
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 5). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
Invitrogen Cd44 antibody (eBioscience, 61-0441) was used in flow cytometry on mouse samples (fig 6). Clin Cancer Res (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig s6b
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen Cd44 antibody (eBioscience, IMF) was used in flow cytometry on mouse samples at 1:200 (fig s6b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to report that the majority of microbe-specific naive T cells produced memory cells during infection, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). Dis Model Mech (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s12
Invitrogen Cd44 antibody (ebioscience, 15-0441-83) was used in flow cytometry on mouse samples (fig s12). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; fig 1
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:800 (fig 1). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen Cd44 antibody (eBiocience, IM7) was used in flow cytometry on mouse samples (fig 3). Nature (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; domestic horse; 1:200; fig 1
Invitrogen Cd44 antibody (eBioscience, 17-0441-81) was used in immunohistochemistry on domestic horse samples at 1:200 (fig 1). Stem Cell Reports (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2a
In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, Invitrogen Cd44 antibody (eBioscience, IM-7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, 11-0441-81) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, Invitrogen Cd44 antibody (eBioscience, 17-0441) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
Invitrogen Cd44 antibody (eBioscience, 48-0441-82) was used in flow cytometry on mouse samples (fig 6). Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Nat Genet (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 0.2 ug/ml; fig 2
In order to investigate how CD44 modulation induced resistance to type 1 diabetes in NOD mice, Invitrogen Cd44 antibody (Thermo Scientific, MA1-10225) was used in immunohistochemistry on mouse samples at 0.2 ug/ml (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2e
  • flow cytometry; human; 1:100; fig 2g
  • immunocytochemistry; human; 1:100; fig 3e
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, Invitrogen Cd44 antibody (eBioscience, IM7) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2e), in flow cytometry on human samples at 1:100 (fig 2g) and in immunocytochemistry on human samples at 1:100 (fig 3e). Stem Cells Transl Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; rat; fig 2
Invitrogen Cd44 antibody (eBioscience, 12-0441) was used in flow cytometry on rat samples (fig 2). Mol Med Rep (2016) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; cat; fig 2
In order to determine the safety of intraperitoneal injection in cats in adipose tissue-derived autologous mesenchymal stem cells, Invitrogen Cd44 antibody (Invitrogen, IM7.8.1) was used in flow cytometry on cat samples (fig 2). J Vet Intern Med (2016) ncbi
rat monoclonal (9A4)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Invitrogen Cd44 antibody (eBioscience, 9A4) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in immunohistochemistry - paraffin section on mouse samples . Nat Immunol (2015) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 7
In order to study the contribution of IL-7 to pneumocystis pneumonia, Invitrogen Cd44 antibody (Invitrogen, RM5726) was used in flow cytometry on mouse samples (fig 7). Infect Immun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to explore the impact of chronic antigenic stimulation on CD4(+) T cell dynamics, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3). Oncotarget (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 1c
Invitrogen Cd44 antibody (eBioscience, (48-0441-82) was used in flow cytometry on mouse samples at 1:100 (fig 1c). Stem Cell Reports (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen Cd44 antibody (eBiosciences, 1M7) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). Immunity (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; human; fig s8
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen Cd44 antibody (ebiosciences, IM7) was used in immunohistochemistry - paraffin section on human samples (fig s8). Nat Biotechnol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
Invitrogen Cd44 antibody (eBioscience, 17-0441-82) was used in flow cytometry on mouse samples (fig s1). Cell Death Dis (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7b
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7b). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1
Invitrogen Cd44 antibody (eBioscience, 47-0441-80) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; tbl 5
In order to test if platelet-derived growth factor receptor-alpha inhibition reduces proliferation of mutant KIT-expressing gastrointestinal stromal tumor cells via ETV1, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on human samples (tbl 5). Gastroenterology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; fig 4
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig 4). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
Invitrogen Cd44 antibody (eBioscience, 11-0441) was used in flow cytometry on mouse samples (fig 4). EMBO Mol Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2
Invitrogen Cd44 antibody (eBioscience, 48-0441) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human
Invitrogen Cd44 antibody (Ebioscience, 11-0441) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • western blot; mouse; 1:100; fig 5,6
Invitrogen Cd44 antibody (eBioscience, IM7) was used in western blot on mouse samples at 1:100 (fig 5,6). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; tbl s3
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
Invitrogen Cd44 antibody (e-Bioscience, IM7) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Oncogene (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:50; fig 1
In order to characterize human tracheal basal cells, Invitrogen Cd44 antibody (eBioscience, 14-0441-81) was used in flow cytometry on human samples at 1:50 (fig 1). Respir Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Immunol Lett (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to investigate the role of Rpl22 during early B cell development, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . elife (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Immunology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6c
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6c). Nat Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 5 ul/test
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on human samples at 5 ul/test. Cytometry B Clin Cytom (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2015) ncbi
rat monoclonal (9A4)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to assess CD44 and CD24 expression in patients with gastric cancer and to evaluate their prognostic values, Invitrogen Cd44 antibody (Thermo Fisher Scientific, MA1-81995) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). BMC Gastroenterol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; human
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to assess the contribution of Tbx1 to thymus and parathyroid development, Invitrogen Cd44 antibody (eBioscience, clone IM7) was used in flow cytometry on mouse samples . Development (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study Bacillus Calmette-Guerin DeltaureC::hly and the superior protection against tuberculosis caused by central memory CD4+ T cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Infect Dis (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the immunogenicity and immunomodulatory properties of bone marrow-derived mesenchymal stem cells using an allogeneic mouse model, Invitrogen Cd44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples . J Tissue Eng (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience Inc., IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:600
In order to demonstrate the heritable downregulation of CD8 during type 2 polarization of murine CD8 positive effector T cells is associated with CpG methylation of the Cd8a locus, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:600. Nat Commun (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; bovine
Invitrogen Cd44 antibody (eBioscience, 12-0441) was used in flow cytometry on bovine samples . Tissue Eng Part A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:10
Invitrogen Cd44 antibody (eBioscience, 45-0441-80) was used in flow cytometry on human samples at 1:10. Odontology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100
Invitrogen Cd44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples at 1:100. Cell Transplant (2015) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 6
In order to confirm the importance of complement for the ability of specific IgM to enhance antibody responses, Invitrogen Cd44 antibody (Life technologies, clone IM7.8.1) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s9
In order to generate and characterize Hoxb8-FL cells, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig s9). Nat Methods (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5a). PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
In order to use a mouse model to examine the link between the microbiota and atopic dermatitis, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2). J Invest Dermatol (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Biomed Res Int (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen Cd44 antibody (eBioscience, IM-7) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of BTB-ZF factors in lymphoid effector programs, Invitrogen Cd44 antibody (e-Bioscience, IM7) was used in flow cytometry on mouse samples . Nature (2012) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to study the kinetics of iNKT cell precursors, Invitrogen Cd44 antibody (Caltag Laboratories, IM7.8.1) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to characterize mice that constitutively expresses the GITR ligand on APCs, Invitrogen Cd44 antibody (Invitrogen, RM5726) was used in flow cytometry on mouse samples . Eur J Immunol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Front Immunol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate age- and antigen-specific CD8 T cell responses, Invitrogen Cd44 antibody (e-Bioscience, IM-7) was used in flow cytometry on mouse samples . PLoS Pathog (2011) ncbi
rat monoclonal (1M7.8.1)
  • flow cytometry; mouse
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen Cd44 antibody (Invitrogen, 1M7) was used in flow cytometry on mouse samples . J Exp Med (2011) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 2
In order to report that development of autoregulatory CD8(+) T cell memory is CD4(+) T cell dependent, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to determine the reconstitution capacity of transferred isolated naive CD8+ T cells, Invitrogen Cd44 antibody (Caltag, IM781) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
rat monoclonal (IM7)
  • western blot; mouse; fig 4b
Invitrogen Cd44 antibody (eBioscience, 14-0441) was used in western blot on mouse samples (fig 4b). Leukemia (2011) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5, 6
In order to report that NAD(+) regulates the survival, phenotype, and function of T regulatory cells via the ART2-P2X7 pathway, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5, 6). J Exp Med (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2010) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; tbl 1
In order to investigate the mucosal inflammatory T-cell immunity induced by Yersinia enterocolitica infection, Invitrogen Cd44 antibody (Caltag, IM-7.8.1) was used in flow cytometry on mouse samples (tbl 1). Infect Immun (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to elucidate the role of AUF1 in the immune system, Invitrogen Cd44 antibody (eBioScience, IM7) was used in flow cytometry on mouse samples (fig 1). BMC Immunol (2010) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to discuss causes of autoimmunity, Invitrogen Cd44 antibody (CALTAG, IM7.8.1) was used in flow cytometry on mouse samples . PLoS ONE (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen Cd44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to study mechanisms of IgG-mediated suppression, Invitrogen Cd44 antibody (Caltag Laboratories, IM7.8.1) was used in flow cytometry on mouse samples . Scand J Immunol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to determine the contribution of CD4+ T cells in the generation of CD8+-T-cell responses following acute infection with HSV-1, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 6
In order to elucidate the role of VAMP8 in the thymus, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 6). Cell Tissue Res (2008) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 5
In order to identify key signals required for the exponential expansion of specific CD8 positive mouse T cells in vivo, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 5). J Immunol (2008) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to elucidate whether UVB exposure inhibits the expansion of effector CD4+ and CD8+ T cells in skin-draining lymph nodes and reduces the number of CD4+ and IFN-gamma+ CD8+ T cells at sites of challenge, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Am J Pathol (2008) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). Blood (2008) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 1
In order to investigate the effect of Stat6 in T cell expansion, survival, and recruitment to the lung, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2008) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the strength and duration of an antigenic signal at initial stimulation and the development and response of effectors and memory cells to secondary stimulation with the same antigen, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Immunology (2008) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; tbl 1
In order to elucidate the role of IL-10 in regulating hepatic injury using IL-10 knockout mice infected with Trichinella spiralis, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2B
In order to discuss the development and functions of effector and memory Foxp3+ T cells, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2B). J Immunol (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen Cd44 antibody (E-Bioscience, 1M7) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to assess how FTY720-treatment affects T cell populations, Invitrogen Cd44 antibody (ebiosciences, IM7) was used in flow cytometry on mouse samples (fig 4). Int Immunopharmacol (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to propose that memory T cells respond to alloantigens initially but fail to fully develop functionally, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). Blood (2007) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to show that a CCR7-dependent migration of lung dendritic cells to the bronchial lymph node is indispensable for tolerance, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . J Immunol (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study recent thymic emigrants in aged mice, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to demonstrate that software designed for transcriptomics applications can be used in multiparameter flow cytometry, Invitrogen Cd44 antibody (ebiosciences, IM7) was used in flow cytometry on mouse samples . Cytometry A (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to examine the role of T-bet in Valpha14i natural killer T cell function, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). Blood (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen Cd44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to test if IgE antibodies modulate T helper cells in vivo, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 3
In order to show that the decrease in T regulatory cell activity in collagen-induced arthritis is counter-regulated by endogenous IFN-gamma, Invitrogen Cd44 antibody (CALTAG Laboratories, IM7.8.1) was used in flow cytometry on mouse samples (fig 3). Arthritis Res Ther (2005) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4A
In order to test if a pre-existing antigen-specific Th1 response affect the development of Th2 cells in vivo, Invitrogen Cd44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4A). J Immunol (2005) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report two Treg subsets with distinct phenotypes and homeostasis in normal unmanipulated mice, Invitrogen Cd44 antibody (Zymed, IM7) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 2
In order to track the dynamics of the antiviral CD8+ T cell responses using a transgenic mouse that marks activated T cells, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 2). J Immunol (2003) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to examine interactions between alloreactive CD4 and CD8 T cells in mixed lymphocyte reactions and in the graft-versus-host reaction, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Immunology (2003) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 6
In order to study the role of host immune cells in the brain of Plasmodium berghei-infected mice, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 6). J Immunol (2002) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to suggest that p38 is involved in positive selection of T cells, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Blood (2003) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to test if T-cell-specific expression of p300 alters GR-TCR cross talk between thymocytes, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Mol Cell Biol (2002) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 1
In order to investigate the role of integrin adhesion receptors in T cell development, Invitrogen Cd44 antibody (Caltag Laboratories, IM7.8.1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to characterize murine tumor-infiltrating lymphocytes, Invitrogen Cd44 antibody (CalTag, IM7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to determine the signaling duration requirements for priming and clonal expansion of naive cytotoxic T lymphocytes, Invitrogen Cd44 antibody (Caltag, clone IM7.8.1) was used in flow cytometry on mouse samples . Nat Immunol (2001) ncbi
rat monoclonal (1M7.8.1)
  • flow cytometry; mouse; fig 2
In order to report that the lymphoid environment limits T cell proliferation in response to high superantigen levels, Invitrogen Cd44 antibody (Caltag, 1 M.781) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2001) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 1
In order to examine multipotent progenitors from early fetuses, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 1
In order to determine the role of CD28 and CTLA-4 in Th cell differentiation, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2000) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to describe a clonal system that supports the development of T and natural killer cells evenly, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to determine the role of IL-7R signaling in gamma/delta T cell development, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to identify cells that mediate positive selection of CD8(+) T cells, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (1999) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to investigate hyper responsive CD8 T cells, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Int Immunol (1999) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to identify the initial source of IL-4 in early immune responses, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Int Immunol (1998) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to determine the chemotactic responsiveness of thymocyte subsets during their early to late stages of development, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . Blood (1998) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; fig 1
In order to examine the effects of altered signaling thresholds in B lymphocytes using CD19-deficient mice and transgenic mice that expressed human CD19 at varying densities, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (fig 1). J Immunol (1997) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; tbl 1
In order to demonstrate that the Ras/Raf/MAPK pathway is constitutively activated in lck-transformed immature thymoblasts, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples (tbl 1). Int Immunol (1997) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse
In order to test if different activation thresholds distinguish naive from memory CD8+ T cell populations, Invitrogen Cd44 antibody (Caltag, IM7.8.1) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to study CD44 and hyaluronic acid interactions, Invitrogen Cd44 antibody (noco, IM7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (1992) ncbi
rat monoclonal (KM81)
  • flow cytometry; mouse; fig 1
In order to determine the importance of the membrane proximal region of murine CD44 for recognition of hyaluronate, Invitrogen Cd44 antibody (noco, KM81) was used in flow cytometry on mouse samples (fig 1). J Cell Biol (1992) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3g
  • western blot; mouse; loading ...; fig s4c
Abcam Cd44 antibody (Abcam, ab157107) was used in western blot on human samples (fig 3g) and in western blot on mouse samples (fig s4c). Clin Transl Med (2022) ncbi
mouse monoclonal (F10-44-2)
  • flow cytometry; human; fig s3
Abcam Cd44 antibody (Abcam, ab6124) was used in flow cytometry on human samples (fig s3). BMC Cancer (2022) ncbi
domestic rabbit monoclonal (EPR18668)
  • immunohistochemistry - paraffin section; mouse; 1:4000; fig 7d
  • western blot; mouse; 1:4000; fig 7c
Abcam Cd44 antibody (Abcam, ab189524) was used in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig 7d) and in western blot on mouse samples at 1:4000 (fig 7c). Int J Biol Sci (2022) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; rat; 1:1000; fig 1e
Abcam Cd44 antibody (Abcam, ab189524) was used in western blot on rat samples at 1:1000 (fig 1e). Int J Mol Sci (2022) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; human; loading ...; fig 4b
Abcam Cd44 antibody (Abcam, ab189524) was used in western blot on human samples (fig 4b). Thorac Cancer (2022) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; human; 1:1000; loading ...; fig 1d
Abcam Cd44 antibody (Abcam, 189524) was used in western blot on human samples at 1:1000 (fig 1d). Front Oncol (2022) ncbi
rat recombinant (1M7.8.1)
  • immunohistochemistry - frozen section; human; fig 3bv
  • immunohistochemistry - frozen section; African green monkey; loading ...; fig s6a
Abcam Cd44 antibody (Abcam, ab119348) was used in immunohistochemistry - frozen section on human samples (fig 3bv) and in immunohistochemistry - frozen section on African green monkey samples (fig s6a). iScience (2022) ncbi
rat monoclonal (KM201)
  • western blot; mouse; 1:500; loading ...; fig 3a
Abcam Cd44 antibody (Abcam, ab25340) was used in western blot on mouse samples at 1:500 (fig 3a). elife (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
Abcam Cd44 antibody (ABCAM, ab157107) was used in immunohistochemistry - paraffin section on human samples (fig s1). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; loading ...; fig 4d
Abcam Cd44 antibody (Abcam, ab157107) was used in flow cytometry on human samples (fig 4d). J Exp Clin Cancer Res (2021) ncbi
rat recombinant (1M7.8.1)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1e
Abcam Cd44 antibody (Abcam, AB119348) was used in immunohistochemistry on mouse samples at 1:100 (fig 1e). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3b
Abcam Cd44 antibody (Abcam, ab157107) was used in western blot on human samples at 1:1000 (fig 3b). Aging (Albany NY) (2021) ncbi
rat monoclonal (KM201)
  • immunohistochemistry; rat; loading ...; fig 1c
Abcam Cd44 antibody (Abcam, ab25340) was used in immunohistochemistry on rat samples (fig 1c). Eur J Dent (2021) ncbi
domestic rabbit monoclonal (EPR18668)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s3b
Abcam Cd44 antibody (Abcam, ab189524) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s3b). Sci Signal (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 2m
Abcam Cd44 antibody (Abcam, ab157107) was used in western blot on human samples at 1:2000 (fig 2m). Oncogene (2021) ncbi
domestic rabbit monoclonal (EPR18668)
  • immunocytochemistry; human; 1:500; loading ...; fig 5b
Abcam Cd44 antibody (Abcam, ab189524) was used in immunocytochemistry on human samples at 1:500 (fig 5b). elife (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; 1:2000; loading ...
Abcam Cd44 antibody (Abcam, ab157107) was used in immunohistochemistry on rat samples at 1:2000. Biol Proced Online (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; 1:1000; loading ...; fig s1b
Abcam Cd44 antibody (Abcam, ab157107) was used in immunocytochemistry on rat samples at 1:1000 (fig s1b). J Neuroinflammation (2020) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; human; 1:1000; loading ...; fig 4c
Abcam Cd44 antibody (Abcam, ab189524) was used in western blot on human samples at 1:1000 (fig 4c). BMC Gastroenterol (2019) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s3d
Abcam Cd44 antibody (Abcam, ab6124) was used in immunohistochemistry - paraffin section on mouse samples (fig s3d). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; human; 1:3000; fig 1d
Abcam Cd44 antibody (Abcam, ab189524) was used in western blot on human samples at 1:3000 (fig 1d). Mol Med Rep (2019) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; loading ...; fig 2b
  • immunohistochemistry; human; loading ...; fig 2h
Abcam Cd44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples (fig 2b) and in immunohistochemistry on human samples (fig 2h). Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 5f
  • immunohistochemistry; rat; 1:200; loading ...; fig 9a
In order to develop and characterize a rat model of glioma, Abcam Cd44 antibody (Abcam, ab157107) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 5f) and in immunohistochemistry on rat samples at 1:200 (fig 9a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s4g
In order to elucidate novel functions of the senescence-associated secretory in promoting a proregenerative response through the induction of cell plasticity and stemness, Abcam Cd44 antibody (Abcam, ab157107) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s4g). Genes Dev (2017) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; 1:100; loading ...; fig 4a
In order to find that TrpC5 regulates differentiation in colorectal cancer, Abcam Cd44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples at 1:100 (fig 4a). Clin Sci (Lond) (2017) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; human; fig 4a
In order to perform Raman-encoded molecular imaging with five nanoparticle flavors, Abcam Cd44 antibody (Abcam, ab6124) was used in immunohistochemistry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; 1:100; fig 2
In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, Abcam Cd44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples at 1:100 (fig 2). Neoplasia (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; human; 1:400; fig 1b
Abcam Cd44 antibody (Abcam, F10-44-2) was used in immunohistochemistry on human samples at 1:400 (fig 1b). Oncogene (2017) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4c
Abcam Cd44 antibody (Abcam, ab6124) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4c). Biochem Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:10,000; loading ...; fig 5d
Abcam Cd44 antibody (Abcam, ab24504) was used in western blot on rat samples at 1:10,000 (fig 5d). Int J Mol Sci (2016) ncbi
rat monoclonal (KM201)
  • western blot; mouse; 1:500; fig 6
Abcam Cd44 antibody (abcam, ab25340) was used in western blot on mouse samples at 1:500 (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; fig 3
Abcam Cd44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; domestic rabbit; 1:200; fig 5b
  • immunohistochemistry; domestic rabbit; 1:200; fig 5b
Abcam Cd44 antibody (abcam, ab6124) was used in immunocytochemistry on domestic rabbit samples at 1:200 (fig 5b) and in immunohistochemistry on domestic rabbit samples at 1:200 (fig 5b). J Transl Med (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; rat; fig 1
  • flow cytometry; domestic rabbit; fig 1
Abcam Cd44 antibody (Abcam, ab157107) was used in flow cytometry on rat samples (fig 1) and in flow cytometry on domestic rabbit samples (fig 1). Sci Rep (2016) ncbi
rat monoclonal (KM201)
  • blocking or activating experiments; mouse; 20 ug/ml; fig s3
Abcam Cd44 antibody (Abcam, ab25340) was used in blocking or activating experiments on mouse samples at 20 ug/ml (fig s3). PLoS Pathog (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - paraffin section; human; fig 1a
Abcam Cd44 antibody (Abcam, AB6124) was used in immunohistochemistry - paraffin section on human samples (fig 1a). PLoS ONE (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; 1:400; fig 3
In order to study the nuclear translocation of Atox1, Abcam Cd44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples at 1:400 (fig 3). Protein Pept Lett (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; mouse; 1:100; fig 5
Abcam Cd44 antibody (abcam, ab6124) was used in immunohistochemistry on mouse samples at 1:100 (fig 5). Hypertension (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; human
Abcam Cd44 antibody (Abcam, Ab6124) was used in immunohistochemistry on human samples . Circulation (2015) ncbi
mouse monoclonal (F10-44-2)
  • western blot; human; 1:3000
Abcam Cd44 antibody (Abcam, ab6124) was used in western blot on human samples at 1:3000. Nitric Oxide (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - frozen section; mouse; 1:100
  • immunohistochemistry - frozen section; human; 1:100
Abcam Cd44 antibody (Abcam, ab6124) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in immunohistochemistry - frozen section on human samples at 1:100. Stem Cells (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DF1485)
  • western blot; human; fig 4a
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz, sc-7297) was used in western blot on human samples (fig 4a). Mol Cell (2021) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5e
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz Biotechnology, sc-18849) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5e). J Clin Invest (2019) ncbi
mouse monoclonal (DF1485)
  • immunoprecipitation; human; loading ...; fig s2c
  • immunocytochemistry; human; loading ...; fig s2a
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz Biotechnology, sc-7297) was used in immunoprecipitation on human samples (fig s2c), in immunocytochemistry on human samples (fig s2a) and in western blot on human samples (fig 5a). Oncotarget (2016) ncbi
mouse monoclonal (DF1485)
  • other; human; 1:100; loading ...; fig 1a, 1c
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz, sc-7297) was used in other on human samples at 1:100 (fig 1a, 1c). Oncotarget (2015) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; human; fig s5d
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz, sc-7297) was used in immunohistochemistry - paraffin section on human samples (fig s5d). Oncotarget (2015) ncbi
mouse monoclonal (DF1485)
  • flow cytometry; human; fig 1
Santa Cruz Biotechnology Cd44 antibody (santa Cruz, sc-7297) was used in flow cytometry on human samples (fig 1). Biomed Res Int (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz Biotechnology, sc-18849) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Santa Cruz Biotechnology Cd44 antibody (santa Cruz, sc-18849) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Int J Mol Med (2015) ncbi
mouse monoclonal (DF1485)
  • western blot; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Santa Cruz Biotechnology Cd44 antibody (Santa Cruz Biotechnology, sc-7297) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3a
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz, sc-18849) was used in flow cytometry on human samples (fig 3a). Cancer Res (2015) ncbi
mouse monoclonal (DF1485)
  • western blot; human
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz Biotechnology, sc-7297) was used in western blot on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (DF1485)
  • western blot; human
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz, sc-7297) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi
mouse monoclonal (DF1485)
  • western blot; human; fig 5
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz, sc-7297) was used in western blot on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4
  • immunohistochemistry - paraffin section; human; 1:50; fig 5
Santa Cruz Biotechnology Cd44 antibody (Santa, sc-7297) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4) and in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5). Proc Natl Acad Sci U S A (2012) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; 1:50
Santa Cruz Biotechnology Cd44 antibody (Santa Cruz Biotech, sc-18849) was used in immunocytochemistry on mouse samples at 1:50. Reproduction (2010) ncbi
Miltenyi Biotec
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; 1:10; loading ...; fig 1b
Miltenyi Biotec Cd44 antibody (MiltenyiBiotec, 130-102-563) was used in flow cytometry on mouse samples at 1:10 (fig 1b). Biosci Rep (2019) ncbi
rat monoclonal (IM7.8.1)
  • flow cytometry; mouse; loading ...; fig s1
Miltenyi Biotec Cd44 antibody (Miltenyi Biotec, 130-102-563) was used in flow cytometry on mouse samples (fig s1). J Cell Mol Med (2018) ncbi
Bio-Rad
rat monoclonal (9A4)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4e
Bio-Rad Cd44 antibody (Serotec, 9A4) was used in immunohistochemistry on mouse samples at 1:100 (fig 4e). Nature (2019) ncbi
Cell Signaling Technology
mouse monoclonal (8E2)
  • immunohistochemistry - paraffin section; human; fig 7i
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Cd44 antibody (Cell Signaling, 5640) was used in immunohistochemistry - paraffin section on human samples (fig 7i) and in western blot on human samples (fig 3d). Sci Adv (2022) ncbi
mouse monoclonal (8E2)
  • western blot; human; loading ...; fig 1d, s2d, s2e, s2f
Cell Signaling Technology Cd44 antibody (Cell Signaling, 5640) was used in western blot on human samples (fig 1d, s2d, s2e, s2f). Mol Cancer (2019) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry - paraffin section; human; fig 6b
  • immunocytochemistry; human; loading ...; fig 1e
In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, Cell Signaling Technology Cd44 antibody (Cell Signaling, 5640) was used in immunohistochemistry - paraffin section on human samples (fig 6b) and in immunocytochemistry on human samples (fig 1e). Mol Cancer Res (2017) ncbi
mouse monoclonal (8E2)
  • flow cytometry; mouse; loading ...; fig 2a
Cell Signaling Technology Cd44 antibody (cell signalling, 5640) was used in flow cytometry on mouse samples (fig 2a). J Hepatol (2017) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry; human; 1:100; fig 6
Cell Signaling Technology Cd44 antibody (Cell Signaling Tech, 5640) was used in immunohistochemistry on human samples at 1:100 (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (8E2)
  • western blot; human; 1:1000; loading ...; fig 5C
Cell Signaling Technology Cd44 antibody (Cell Sgnaling, 5640) was used in western blot on human samples at 1:1000 (fig 5C). Mol Oncol (2016) ncbi
mouse monoclonal (8E2)
  • western blot; human; fig 1a,b
Cell Signaling Technology Cd44 antibody (Cell Signaling Technology., 5640S) was used in western blot on human samples (fig 1a,b). Nucleic Acids Res (2016) ncbi
mouse monoclonal (8E2)
  • immunocytochemistry; rat
In order to study the effect of bile acids on mesenchymal stem cells in liver, Cell Signaling Technology Cd44 antibody (Cell Signaling, 5640S) was used in immunocytochemistry on rat samples . Sci Rep (2015) ncbi
mouse monoclonal (8E2)
  • blocking or activating experiments; mouse
Cell Signaling Technology Cd44 antibody (Cell Signaling Technology, 5640) was used in blocking or activating experiments on mouse samples . J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology Cd44 antibody (Cell Signaling Technology, 5640) was used in western blot on human samples at 1:1000 (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (8E2)
  • immunocytochemistry; human; 1:800
  • western blot; human
Cell Signaling Technology Cd44 antibody (Cell Signaling Technology, 5640) was used in immunocytochemistry on human samples at 1:800 and in western blot on human samples . Int J Oncol (2015) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry - free floating section; human; 1:2000
Cell Signaling Technology Cd44 antibody (Cell Signaling, #5640) was used in immunohistochemistry - free floating section on human samples at 1:2000. J Cell Physiol (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human; fig 2
Cell Signaling Technology Cd44 antibody (Cell Signaling, 5640) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human
In order to investigate the role of TLR3 signaling in breast cancer stem cells, Cell Signaling Technology Cd44 antibody (cell signaling, 5640) was used in western blot on human samples . Cell Death Differ (2015) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry; human
Cell Signaling Technology Cd44 antibody (Cell Signaling, 5640s) was used in immunohistochemistry on human samples . Cancer Res (2014) ncbi
Tonbo Biosciences
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3d
Tonbo Biosciences Cd44 antibody (Tonbo Biosciences, IM7) was used in flow cytometry on mouse samples (fig 3d). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:20; loading ...; fig s4a
Tonbo Biosciences Cd44 antibody (Tonbo biosciences, IM7) was used in flow cytometry on mouse samples at 1:20 (fig s4a). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Tonbo Biosciences Cd44 antibody (TONBO, IM7) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 1a
Tonbo Biosciences Cd44 antibody (Tonbo, 65-0441-U100) was used in flow cytometry on mouse samples at 1:800 (fig 1a). Science (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
Tonbo Biosciences Cd44 antibody (Tonbo Biosciences, IM7) was used in flow cytometry on mouse samples (fig 6b). JCI Insight (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
Tonbo Biosciences Cd44 antibody (Tonbo, IM7) was used in flow cytometry on mouse samples (fig 2e). J Virol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to determine the role of CD6 in T cells using knock out mice, Tonbo Biosciences Cd44 antibody (TONBO Bioscience, IM7) was used in flow cytometry on mouse samples (fig 2d). J Exp Med (2016) ncbi
Stemcell Technologies
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 2a
Stemcell Technologies Cd44 antibody (StemCell Technologies, 60068) was used in immunocytochemistry on human samples (fig 2a). Cell (2018) ncbi
BD Biosciences
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:600; loading ...; fig 3a
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples at 1:600 (fig 3a). Clin Transl Immunology (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 1d, 3e
BD Biosciences Cd44 antibody (BD Horizon, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 1d, 3e). J Neuroinflammation (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 4b). Nature (2022) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 8a
BD Biosciences Cd44 antibody (BD Pharmingen, 550538) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 8a). BMC Cancer (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5m
BD Biosciences Cd44 antibody (BD Biosciences, 553134) was used in flow cytometry on mouse samples at 1:100 (fig 5m). Nat Commun (2022) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6i
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 6i). Sci Rep (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences Cd44 antibody (BD Pharmingen, 560569) was used in flow cytometry on mouse samples (fig 3b). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 5d
BD Biosciences Cd44 antibody (BD, 553134) was used in flow cytometry on mouse samples at 1:200 (fig 5d). Cell Biosci (2021) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 6w
BD Biosciences Cd44 antibody (BD Pharmingen, 550538) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 6w). Front Cell Dev Biol (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2c
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 2c). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; mouse; 50 ug/mouse; fig 3s1a
  • immunoprecipitation; mouse; loading ...; fig 3a
BD Biosciences Cd44 antibody (BD Pharmingen, 553131) was used in blocking or activating experiments on mouse samples at 50 ug/mouse (fig 3s1a) and in immunoprecipitation on mouse samples (fig 3a). elife (2021) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3a
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3a). Sci Adv (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences Cd44 antibody (BD Pharmingen, 559250) was used in flow cytometry on human samples (fig 1a). elife (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c, 2d
BD Biosciences Cd44 antibody (BD Bioscience, 561859) was used in flow cytometry on mouse samples (fig 2c, 2d). Cancers (Basel) (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:125; loading ...
BD Biosciences Cd44 antibody (BD Biosciences, 560568) was used in flow cytometry on human samples at 1:125. Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s12b
BD Biosciences Cd44 antibody (BD PharmingenTM, 553133) was used in flow cytometry on mouse samples (fig s12b). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig s8
BD Biosciences Cd44 antibody (BD Pharmingen, 553133) was used in flow cytometry on mouse samples at 1:200 (fig s8). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2f
BD Biosciences Cd44 antibody (BD Bioscience, 560569) was used in flow cytometry on mouse samples (fig s2f). Sci Adv (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples . EMBO Mol Med (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c, e8c
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 3c, e8c). Nat Neurosci (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 4b). elife (2021) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 6c
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6c). Nat Commun (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BD Biosciences Cd44 antibody (BD Biosciences, 560570) was used in flow cytometry on mouse samples . J Clin Invest (2021) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 8a
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 8a). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:2000; loading ...; fig 3b
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples at 1:2000 (fig 3b). elife (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; loading ...; fig 1a
BD Biosciences Cd44 antibody (BD Pharmingen, 550,538) was used in immunohistochemistry on mouse samples (fig 1a). Basic Res Cardiol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4e
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 4e). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7a
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 7a). PLoS Biol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). BMC Biol (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; mouse; 1:40; loading ...; fig 5b
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - frozen section on mouse samples at 1:40 (fig 5b). elife (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4h, 4i
BD Biosciences Cd44 antibody (BD, 550538) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4h, 4i). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • mass cytometry; mouse; 0.375 ug/ml; loading ...; fig 5d
BD Biosciences Cd44 antibody (BD, IM7) was used in mass cytometry on mouse samples at 0.375 ug/ml (fig 5d). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 4e
BD Biosciences Cd44 antibody (BD Biosciences, 553133) was used in flow cytometry on mouse samples at 1:200 (fig 4e). Nat Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4b
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig s4b). JCI Insight (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences Cd44 antibody (BD Pharmingen, 560567) was used in flow cytometry on mouse samples (fig 3b). Int Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences Cd44 antibody (BD Biosciences, 560569) was used in flow cytometry on mouse samples (fig s1a). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
BD Biosciences Cd44 antibody (BD PharMingen, IM7) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 4e
BD Biosciences Cd44 antibody (Pharmingen, IM7) was used in immunohistochemistry on mouse samples at 1:50 (fig 4e). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; ; loading ...; fig s1b
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples at (fig s1b). Science (2019) ncbi
rat monoclonal (IM7)
  • mass cytometry; human; loading ...; fig 3a
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1b
BD Biosciences Cd44 antibody (BD Biosciences, 560781) was used in flow cytometry on mouse samples (fig s1b). Sci Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1e). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
BD Biosciences Cd44 antibody (Bd Bioscience, 550538) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). Cell Stem Cell (2019) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3f
BD Biosciences Cd44 antibody (BD, 553131) was used in immunohistochemistry - paraffin section on mouse samples (fig 3f). Cell Death Differ (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig s1a). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3d
BD Biosciences Cd44 antibody (BD, 553134) was used in flow cytometry on mouse samples (fig 3d). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s5). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2f
BD Biosciences Cd44 antibody (BD, 561859) was used in flow cytometry on mouse samples (fig 2f). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s7d
BD Biosciences Cd44 antibody (BD, 553133) was used in flow cytometry on mouse samples (fig s7d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s7d
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig s7d). Cancer Immunol Immunother (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig s7d
BD Biosciences Cd44 antibody (BD Biosciences, 559250) was used in flow cytometry on mouse samples at 1:200 (fig s7d). Nat Neurosci (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
BD Biosciences Cd44 antibody (BD Biosciences, 553133) was used in flow cytometry on mouse samples (fig 2c). Cell Death Dis (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences Cd44 antibody (BD Biosciences, 553134) was used in flow cytometry on mouse samples (fig s1a). Immunity (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences Cd44 antibody (BD Bioscience, 560451) was used in flow cytometry on human samples (fig s1a). Immunity (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1b
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s1b). Infect Immun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig s1a). EBioMedicine (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 4a). Int J Cancer (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
BD Biosciences Cd44 antibody (Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s7a
BD Biosciences Cd44 antibody (BD Biosciences, 553134) was used in flow cytometry on mouse samples (fig s7a). Science (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s6g
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s6g). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3e
BD Biosciences Cd44 antibody (BD Bioscience, 553135) was used in flow cytometry on mouse samples (fig 3e). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1d
BD Biosciences Cd44 antibody (BD Biosciences, 560570) was used in flow cytometry on mouse samples (fig 1d). Cancer Cell (2017) ncbi
rat monoclonal (KM114)
  • western blot; human; loading ...; fig 3a
BD Biosciences Cd44 antibody (BD Transduction Labs, 558739) was used in western blot on human samples (fig 3a). Cancer Res (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, BD Biosciences Cd44 antibody (BD Bioscience, 560567) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1d
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s1d). Cell Death Differ (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
In order to investigate the role of the E-Id protein axis in the innate and adaptive lymphoid development, BD Biosciences Cd44 antibody (BD Biosciences, 559250) was used in flow cytometry on mouse samples (fig 2e). Immunity (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3
In order to investigate the regulated egress of T-cell subsets from tumors, BD Biosciences Cd44 antibody (BD Bioscience, IM7) was used in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2017) ncbi
  • immunohistochemistry; mouse; 1:200; loading ...; fig 5c
BD Biosciences Cd44 antibody (Millipore, 217594) was used in immunohistochemistry on mouse samples at 1:200 (fig 5c). Acta Neuropathol Commun (2017) ncbi
rat monoclonal (IM7)
  • western blot; mouse; loading ...; fig 1a
BD Biosciences Cd44 antibody (BD Pharmingen, 553131) was used in western blot on mouse samples (fig 1a). J Hepatol (2017) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; 1:100; fig 3b
BD Biosciences Cd44 antibody (BD Biosciences, 553132) was used in immunocytochemistry on mouse samples at 1:100 (fig 3b). Sci Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a, 3b
BD Biosciences Cd44 antibody (BD, 553133) was used in flow cytometry on mouse samples (fig 3a, 3b). Stem Cells Int (2017) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s4g
In order to elucidate novel functions of the senescence-associated secretory in promoting a proregenerative response through the induction of cell plasticity and stemness, BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s4g). Genes Dev (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1b
In order to test if dermal gammadelta cells freely re-circulate out of skin, or behave like dermal resident memory T cells in mice, BD Biosciences Cd44 antibody (BD PharMingen, IM7) was used in flow cytometry on mouse samples (fig s1b). PLoS ONE (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s6a
In order to find microenvironmental regulators of metastatic colonization, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s6a). Nature (2017) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 2b
  • western blot; mouse; 1:1000; fig 4d
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry on mouse samples at 1:50 (fig 2b) and in western blot on mouse samples at 1:1000 (fig 4d). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1c). Nat Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; black flying fox; 1 ug/ml; loading ...; fig 1a
In order to describe the phenotypic and functional characterization of T cell subsets, B and NK cells in the fruit-eating bat Pteropus alecto, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on black flying fox samples at 1 ug/ml (fig 1a). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 4b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3a
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on human samples (fig 3a). J Virol (2017) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; loading ...; fig 1b
  • western blot; mouse; loading ...; fig 1c
In order to generate and characterize mice that lack CD44 in the skin, BD Biosciences Cd44 antibody (BD Biosciences,, IM7) was used in immunohistochemistry on mouse samples (fig 1b) and in western blot on mouse samples (fig 1c). Cell Death Dis (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 3a
In order to propose a tumor-suppressive activity for macrophage migration inhibitory factor in murine skin, BD Biosciences Cd44 antibody (Becton Dickinson, IM7) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 3a). FASEB J (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4a
In order to explore the role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s4a). Brain (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to study the role of TMEM16F in limiting T cell responses in mice infected with virus, BD Biosciences Cd44 antibody (BD, 553133) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1c). Mol Cell Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5A
In order to examine the thymic microenvironment using a model of paracoccidioidomycosis, BD Biosciences Cd44 antibody (BD Pharmigen, IM7) was used in flow cytometry on mouse samples (fig 5A). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences Cd44 antibody (BD Biosciences, 561862) was used in flow cytometry on mouse samples (fig s2a). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 10
BD Biosciences Cd44 antibody (BD PharMingen, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 10). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1
In order to explore the role of GABAergic signaling in mesenchymal stem cell-mediated immunosuppression, BD Biosciences Cd44 antibody (BD Biosciences, 553134) was used in flow cytometry on human samples (fig 1). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 7m
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 7m). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to explore signaling pathways regulated by RLTPR in T and B cells, BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BD Biosciences Cd44 antibody (BD, 553133) was used in flow cytometry on mouse samples . Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
In order to demonstrate that DNMT3a directs early CD8 positive T-cell effector and memory fate decisions, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s6a
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s6a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
In order to examine the impact of emergency granulopoiesis on T and B cell function, BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
In order to suggest that lung group 2 innate lymphoid cells promote B cell production of early antibodies to a respiratory antigen even in the absence of T cells, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s2). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences Cd44 antibody (BD Biosciences, 560780) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; mouse; 1 ug/ml; fig 8
BD Biosciences Cd44 antibody (BD, IM7) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 8). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1c
  • western blot; mouse; loading ...; fig 2a
In order to determine the function of CD24 using a mouse model of pancreatic ductal adenocarcinoma and cerulein-induced acute pancreatitis, BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - paraffin section on mouse samples (fig 1c) and in western blot on mouse samples (fig 2a). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 2
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 7
BD Biosciences Cd44 antibody (BD Biosciences, 559250) was used in flow cytometry on mouse samples at 1:100 (fig 7). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). Eur J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:100; loading ...; fig 1b
BD Biosciences Cd44 antibody (BD Biosciences, 559250) was used in flow cytometry on human samples at 1:100 (fig 1b). Oncol Lett (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 3
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on human samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig s4
BD Biosciences Cd44 antibody (BD Biosciences, 559250) was used in flow cytometry on mouse samples at 1:200 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1a
In order to elucidate the mechanisms by which fetal-type hemoglobin is repressed, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD, 559250) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BD Biosciences Cd44 antibody (BD, IM-7) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s9
BD Biosciences Cd44 antibody (BD Biosciences, 553134) was used in flow cytometry on mouse samples (fig s9). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2b
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig s2b). Nat Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to study apolipoprotein-1 during normocholesterolemic conditions, BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
BD Biosciences Cd44 antibody (BD Biosciences, 561860) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig s17a
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples at 1:100 (fig s17a). J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
BD Biosciences Cd44 antibody (BD Bioscience, 1M7) was used in flow cytometry on mouse samples (fig 6a). J Virol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:50; fig s1
BD Biosciences Cd44 antibody (BD Biosciences, 561859) was used in flow cytometry on mouse samples at 1:50 (fig s1). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Front Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig s4
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples at 1:200 (fig s4). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4
In order to show that CD4 positive T cells and ILC2s together block Nippostrongylus brasiliensis development in the parenchyma, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 4). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, 553133) was used in flow cytometry on mouse samples . Stem Cell Res Ther (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig s2
BD Biosciences Cd44 antibody (BD Bioscience, 561862) was used in flow cytometry on human samples (fig s2). EMBO Mol Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Immun Inflamm Dis (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:50; fig 2a
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples at 1:50 (fig 2a). Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; fig s13
BD Biosciences Cd44 antibody (BD, 560567) was used in flow cytometry on mouse samples at 1:400 (fig s13). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to elucidate the mechanisms by which RANKL promotes bone formation and erosion, BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 1). J Bone Miner Res (2015) ncbi
rat monoclonal (IM7)
  • western blot; mouse
BD Biosciences Cd44 antibody (Becton Dickinson, IM7) was used in western blot on mouse samples . Mol Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 1:800
In order to investigate the role of Fgf10 in the development of the vertebrate inner ear, BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry on mouse samples at 1:800. Dev Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples (fig 6). J Virol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to report that GP96 is required for T regulatory cell maintenance and function, BD Biosciences Cd44 antibody (BD Biosciences, 1M7) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:50
In order to evaluate an in vitro murine-derived fundic organoids for the study of gastric physiology, BD Biosciences Cd44 antibody (BD Pharmingen, 561859) was used in flow cytometry on mouse samples at 1:50. J Physiol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Vaccines (Basel) (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to identify DUBA as a suppressor of IL-17 production in T cells, BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples . Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
BD Biosciences Cd44 antibody (BD, IM7) was used in flow cytometry on mouse samples (fig 3). Gut (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
In order to report that CLEC-2 modulation of podoplanin signaling permits fibroblastic reticular cell networks to stretch, which allows for rapid lymph node expansion, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig s2). Nature (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Immunobiology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Pharmingen, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to examine the quantitative and temporal requirements of Zap70's function in thymocyte development, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . J Biol Chem (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, 559250) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM-7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the role of CD4 T cells during mixed antibody-mediated rejection of renal allografts, BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Am J Transplant (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study a postnatal thymus population of multipotent mesenchymal stem-like cells, BD Biosciences Cd44 antibody (BD Bioscience, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Diabetes (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD Biosciences, IM7) was used in flow cytometry on mouse samples . Mucosal Immunol (2014) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - paraffin section on human samples at 1:100. Pancreas (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BD Biosciences Cd44 antibody (BD, 553133) was used in flow cytometry on mouse samples at 1:200. PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse
BD Biosciences Cd44 antibody (BD Biosciences, 550538) was used in immunohistochemistry - paraffin section on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; mouse
In order to study the role of endothelial-to-mesenchymal transition in the onset and progression of cerebral cavernous malformations, BD Biosciences Cd44 antibody (BD Biosciences, 553131) was used in immunohistochemistry - frozen section on mouse samples . Nature (2013) ncbi
rat monoclonal (KM114)
  • immunohistochemistry; mouse; 1:50
BD Biosciences Cd44 antibody (BD Pharmingen, 558739) was used in immunohistochemistry on mouse samples at 1:50. Oncogene (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
BD Biosciences Cd44 antibody (BD, 553134) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; mouse
BD Biosciences Cd44 antibody (BD, 553131) was used in blocking or activating experiments on mouse samples . Proc Natl Acad Sci U S A (2012) ncbi
rat monoclonal (IM7)
  • chromatin immunoprecipitation; mouse
BD Biosciences Cd44 antibody (BD-Pharmingen, IM7) was used in chromatin immunoprecipitation on mouse samples . J Immunol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BD Biosciences Cd44 antibody (BD, 553133) was used in flow cytometry on mouse samples . J Immunol (2011) ncbi
rat monoclonal (IM7)
  • flow cytometry; human
BD Biosciences Cd44 antibody (BD Biosciences, 553133) was used in flow cytometry on human samples . J Immunol (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
In order to propose a revised model of early T cell development, BD Biosciences Cd44 antibody (PharMingen, IM7) was used in flow cytometry on mouse samples (fig 5). J Immunol (1994) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (5D2-27)
  • western blot knockout validation; mouse; fig 2b
Developmental Studies Hybridoma Bank Cd44 antibody (DSHB, 5D2-27) was used in western blot knockout validation on mouse samples (fig 2b). Cell (2018) ncbi
Articles Reviewed
  1. Chi J, Hsiao Y, Liang H, Huang T, Chen F, Chen C, et al. Blockade of the pentraxin 3/CD44 interaction attenuates lung injury-induced fibrosis. Clin Transl Med. 2022;12:e1099 pubmed publisher
  2. Tran N, Ferreira L, Alvarez Moya B, Buttiglione V, Ferrini B, Zordan P, et al. Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier. elife. 2022;11: pubmed publisher
  3. O Shea T, Ao Y, Wang S, Wollenberg A, Kim J, Ramos Espinoza R, et al. Lesion environments direct transplanted neural progenitors towards a wound repair astroglial phenotype in mice. Nat Commun. 2022;13:5702 pubmed publisher
  4. Dong N, Zhou P, Li D, Zhu H, Liu L, Ma H, et al. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways. World J Stem Cells. 2022;14:556-576 pubmed publisher
  5. Chen Y, Lu C, Cheng W, Kuo K, Yu C, Ho H, et al. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids. BMC Cancer. 2022;22:967 pubmed publisher
  6. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  7. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  8. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  9. Tang Y, Dong L, Zhang C, Li X, Li R, Lin H, et al. PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis. Int J Biol Sci. 2022;18:4329-4340 pubmed publisher
  10. Bradford B, McGuire L, Hume D, Pridans C, Mabbott N. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain. Glia. 2022;70:2169-2187 pubmed publisher
  11. Zhao X, Hu S, Zeng L, Liu X, Song Y, Zhang Y, et al. Irradiation combined with PD-L1-/- and autophagy inhibition enhances the antitumor effect of lung cancer via cGAS-STING-mediated T cell activation. iScience. 2022;25:104690 pubmed publisher
  12. Burn O, Farrand K, Pritchard T, Draper S, Tang C, Mooney A, et al. Glycolipid-peptide conjugate vaccines elicit CD8+ T-cell responses and prevent breast cancer metastasis. Clin Transl Immunology. 2022;11:e1401 pubmed publisher
  13. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  14. Liu H, He J, Bagheri Yarmand R, Li Z, Liu R, Wang Z, et al. Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. Nat Commun. 2022;13:3684 pubmed publisher
  15. Li J, Camirand A, Zakikhani M, Sellin K, Guo Y, Luan X, et al. Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal. JBMR Plus. 2022;6:e10587 pubmed publisher
  16. Ebrahim N, Al Saihati H, Mostafa O, Hassouna A, Abdulsamea S, Abd El Aziz M El Gebaly E, et al. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway. Int J Mol Sci. 2022;23: pubmed publisher
  17. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  18. Wang Q, Bergholz J, Ding L, Lin Z, Kabraji S, Hughes M, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022;13:3022 pubmed publisher
  19. Koutn xed k J, Klepsch V, Pommermayr M, Thuille N, Baier G, Siegmund K. A MLR-Based Approach to Analyze Regulators of T Lymphocyte Activation In Vivo. Int J Mol Sci. 2022;23: pubmed publisher
  20. Chen Y, Xu J, Pan W, Xu X, Ma X, Chu Y, et al. Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cells. Thorac Cancer. 2022;13:1961-1973 pubmed publisher
  21. Taniguchi H, Caeser R, Chavan S, Zhan Y, Chow A, Manoj P, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Rep. 2022;39:110814 pubmed publisher
  22. Liu X, Wang Z, Yang Q, Hu X, Fu Q, Zhang X, et al. RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53. Front Oncol. 2022;12:858694 pubmed publisher
  23. Benkhoucha M, Tran N, Breville G, Senoner I, Bradfield P, Papayannopoulou T, et al. CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation. J Neuroinflammation. 2022;19:103 pubmed publisher
  24. Tanton H, Sewastianik T, Seo H, Remillard D, Pierre R, Bala P, et al. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Sci Adv. 2022;8:eabm3108 pubmed publisher
  25. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  26. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  27. Kleinberger I, Sanders E, Staes K, Van Troys M, Hirano S, Hochepied T, et al. Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms. BMC Cancer. 2022;22:451 pubmed publisher
  28. Cortes J, Filip I, Albero R, Patiño Galindo J, Quinn S, Lin W, et al. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Rep. 2022;39:110695 pubmed publisher
  29. Ngamsri K, Fuhr A, Schindler K, Simelitidis M, Hagen M, Zhang Y, et al. Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1. Cells. 2022;11: pubmed publisher
  30. van der Heide V, Jangra S, Cohen P, Rathnasinghe R, Aslam S, Aydillo T, et al. Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep. 2022;38:110508 pubmed publisher
  31. Lopes N, Boucherit N, Santamaria J, Provin N, Charaix J, Ferrier P, et al. Thymocytes trigger self-antigen-controlling pathways in immature medullary thymic epithelial stages. elife. 2022;11: pubmed publisher
  32. Yang B, Zhang Z, Chen X, Wang X, Qin S, Du L, et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  33. D Addio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V, et al. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis. Nat Commun. 2022;13:684 pubmed publisher
  34. Quách T, Huang W, Sahu R, Diadhiou C, Raparia C, Johnson R, et al. Context-dependent induction of autoimmunity by TNF signaling deficiency. JCI Insight. 2022;7: pubmed publisher
  35. Zhu H, Liu X, DING Y, Tan K, Ni W, Ouyang W, et al. IL-6 coaxes cellular dedifferentiation as a pro-regenerative intermediate that contributes to pericardial ADSC-induced cardiac repair. Stem Cell Res Ther. 2022;13:44 pubmed publisher
  36. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  37. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  38. Yamasaki S, Tu H, Matsuyama T, Horiuchi M, Hashiguchi T, Sho J, et al. A Genetic modification that reduces ON-bipolar cells in hESC-derived retinas enhances functional integration after transplantation. iScience. 2022;25:103657 pubmed publisher
  39. Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer Lambertz S, St xf6 rk T, et al. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection. Sci Rep. 2021;11:23819 pubmed publisher
  40. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  41. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  42. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  43. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  44. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed publisher
  45. Wright J, Bazile C, Clark E, Carlesso G, Boucher J, Kleiman E, et al. Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk. Front Immunol. 2021;12:705307 pubmed publisher
  46. Huang Z, Feng J, Feng X, Chan L, Lu J, Lei L, et al. Loss of signal transducer and activator of transcription 3 impaired the osteogenesis of mesenchymal progenitor cells in vivo and in vitro. Cell Biosci. 2021;11:172 pubmed publisher
  47. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  48. Sun H, Wang T, Atkinson P, Billings S, Dong W, Cheng A. Gpr125 Marks Distinct Cochlear Cell Types and Is Dispensable for Cochlear Development and Hearing. Front Cell Dev Biol. 2021;9:690955 pubmed publisher
  49. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  50. Winn N, Wolf E, Cottam M, Bhanot M, Hasty A. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice. Am J Physiol Endocrinol Metab. 2021;321:E376-E391 pubmed publisher
  51. Funk K, Arutyunov A, Desai P, White J, Soung A, Rosen S, et al. Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis. Aging Cell. 2021;20:e13412 pubmed publisher
  52. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  53. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  54. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  55. Mai J, Li Z, Xia X, Zhang J, Li J, Liu H, et al. Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine. Adv Sci (Weinh). 2021;8:2100166 pubmed publisher
  56. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  57. Ryu S, Shchukina I, Youm Y, Qing H, Hilliard B, Dlugos T, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. elife. 2021;10: pubmed publisher
  58. Lacy M, Burger C, Shami A, Ahmadsei M, Winkels H, Nitz K, et al. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun. 2021;12:3754 pubmed publisher
  59. Ho D, Tsui Y, Chan L, Sze K, Zhang X, Cheu J, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684 pubmed publisher
  60. Shan Z, Li L, Atkins C, Wang M, Wen Y, Jeong J, et al. Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment. elife. 2021;10: pubmed publisher
  61. Zhao Y, Li Z, Zhu Y, Fu J, Zhao X, Zhang Y, et al. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Adv Sci (Weinh). 2021;8:e2003897 pubmed publisher
  62. Okunuki Y, Tabor S, Lee M, Connor K. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation. Front Immunol. 2021;12:680568 pubmed publisher
  63. Pereira J, Cavaco P, da Silva R, Pacheco Leyva I, Mereiter S, Pinto R, et al. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination. Transl Oncol. 2021;14:101125 pubmed publisher
  64. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  65. Sacchetti A, Teeuwssen M, Verhagen M, Joosten R, Xu T, Stabile R, et al. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. elife. 2021;10: pubmed publisher
  66. Clemen R, Freund E, Mrochen D, Miebach L, Schmidt A, Rauch B, et al. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice. Adv Sci (Weinh). 2021;8:2003395 pubmed publisher
  67. Glassman C, Su L, Majri Morrison S, Winkelmann H, Mo F, Li P, et al. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. elife. 2021;10: pubmed publisher
  68. Li K, Yuan Z, Lyu J, Ahn E, Davis S, Ahmed R, et al. PD-1 suppresses TCR-CD8 cooperativity during T-cell antigen recognition. Nat Commun. 2021;12:2746 pubmed publisher
  69. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  70. Kalinina A, Khromykh L, Kazansky D, Deykin A, Silaeva Y. Suppression of the Immune Response by Syngeneic Splenocytes Adoptively Transferred to Sublethally Irradiated Mice. Acta Naturae. 2021;13:116-126 pubmed publisher
  71. Phong B, D Souza S, Baudier R, Wu E, Immethun V, Bauer D, et al. IgE-activated mast cells enhance TLR4-mediated antigen-specific CD4+ T cell responses. Sci Rep. 2021;11:9686 pubmed publisher
  72. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  73. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  74. Sun X, He Z, Guo L, Wang C, Lin C, Ye L, et al. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer. J Exp Clin Cancer Res. 2021;40:149 pubmed publisher
  75. Catalano A, Adlesic M, Kaltenbacher T, Klar R, Albers J, Seidel P, et al. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers (Basel). 2021;13: pubmed publisher
  76. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  77. Yang C, Kwon D, Kim M, Im S, Lee Y. Commensal Microbiome Expands Tγδ17 Cells in the Lung and Promotes Particulate Matter-Induced Acute Neutrophilia. Front Immunol. 2021;12:645741 pubmed publisher
  78. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  79. Russo A, Colina J, Moy J, Baligod S, Czarnecki A, Varughese P, et al. Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2. Cell Death Dis. 2021;12:375 pubmed publisher
  80. Liu G, Zhao H, Song Q, Li G, Lin S, Xiong S. Long non-coding RNA DPP10-AS1 exerts anti-tumor effects on colon cancer via the upregulation of ADCY1 by regulating microRNA-127-3p. Aging (Albany NY). 2021;13:9748-9765 pubmed publisher
  81. Goldfarb A, Freeman K, Sahu R, Elagib K, Holy M, Arneja A, et al. Iron control of erythroid microtubule cytoskeleton as a potential target in treatment of iron-restricted anemia. Nat Commun. 2021;12:1645 pubmed publisher
  82. Santos Zas I, Lemari xe9 J, Zlatanova I, Cachanado M, Seghezzi J, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12:1483 pubmed publisher
  83. Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
  84. Hamminger P, Marchetti L, Preglej T, Platzer R, Zhu C, Kamnev A, et al. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases. J Autoimmun. 2021;119:102610 pubmed publisher
  85. Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12:240-260 pubmed publisher
  86. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  87. Ostrop J, Zwiggelaar R, Terndrup Pedersen M, Gerbe F, B xf6 sl K, Lindholm H, et al. A Semi-automated Organoid Screening Method Demonstrates Epigenetic Control of Intestinal Epithelial Differentiation. Front Cell Dev Biol. 2020;8:618552 pubmed publisher
  88. Heider M, Eichner R, Stroh J, Morath V, Kuisl A, Zecha J, et al. The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma. Mol Cell. 2021;: pubmed publisher
  89. Chen J, Sivan U, Tan S, Lippo L, De Angelis J, Labella R, et al. High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging. Sci Adv. 2021;7: pubmed publisher
  90. Ziegler D, Vindrieux D, Goehrig D, Jaber S, Collin G, Griveau A, et al. Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging. Nat Commun. 2021;12:720 pubmed publisher
  91. Phan T, Schink L, Mann J, Merk V, Zwicky P, Mundt S, et al. Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Sci Adv. 2021;7: pubmed publisher
  92. Sari R, Revianti S, Andriani D, Prananingrum W, Rahayu R, Sudjarwo S. The Effect of Anadara granosa Shell's-Stichopus hermanni Scaffold on CD44 and IL-10 Expression to Decrease Osteoclasts in Socket Healing. Eur J Dent. 2021;15:228-235 pubmed publisher
  93. Xu K, Yin N, Peng M, Stamatiades E, Shyu A, Li P, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371:405-410 pubmed publisher
  94. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  95. Tyagi A, Sharma S, Wu K, Wu S, Xing F, Liu Y, et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12:474 pubmed publisher
  96. Mastorakos P, Mihelson N, Luby M, Burks S, Johnson K, Hsia A, et al. Temporally distinct myeloid cell responses mediate damage and repair after cerebrovascular injury. Nat Neurosci. 2021;24:245-258 pubmed publisher
  97. Angulo G, Železnjak J, Martínez Vicente P, Puñet Ortiz J, Hengel H, Messerle M, et al. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. elife. 2021;10: pubmed publisher
  98. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  99. Yang J, Kitami M, Pan H, Nakamura M, Zhang H, Liu F, et al. Augmented BMP signaling commits cranial neural crest cells to a chondrogenic fate by suppressing autophagic β-catenin degradation. Sci Signal. 2021;14: pubmed publisher
  100. Wang Z, Shi Y, Ying C, Jiang Y, Hu J. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. Oncogene. 2021;: pubmed publisher
  101. Sanmarco L, Wheeler M, Gutiérrez Vázquez C, Polonio C, Linnerbauer M, Pinho Ribeiro F, et al. Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes. Nature. 2021;: pubmed publisher
  102. Pickering K, Gilroy K, Cassidy J, Fey S, Najumudeen A, Zeiger L, et al. A RAC-GEF network critical for early intestinal tumourigenesis. Nat Commun. 2021;12:56 pubmed publisher
  103. Suah A, Tran D, Khiew S, Andrade M, Pollard J, Jain D, et al. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021;131: pubmed publisher
  104. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  105. Grand M, Waqasi M, Demarta Gatsi C, Wei Y, Peronet R, Commere P, et al. Hepatic Inflammation Confers Protective Immunity Against Liver Stages of Malaria Parasite. Front Immunol. 2020;11:585502 pubmed publisher
  106. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed publisher
  107. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  108. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  109. Rundqvist H, Veliça P, Barbieri L, Gameiro P, Bargiela D, Gojkovic M, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. elife. 2020;9: pubmed publisher
  110. Kim K, Park T, Cho B, Kim T. Nanoparticles from Equine Fetal Bone Marrow-Derived Cells Enhance the Survival of Injured Chondrocytes. Animals (Basel). 2020;10: pubmed publisher
  111. Lauver M, Goetschius D, Netherby Winslow C, Ayers K, Jin G, Haas D, et al. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence. elife. 2020;9: pubmed publisher
  112. Benavente F, Piltti K, Hooshmand M, Nava A, Lakatos A, Feld B, et al. Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair. elife. 2020;9: pubmed publisher
  113. Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. elife. 2020;9: pubmed publisher
  114. Pseftogas A, Xanthopoulos K, Poutahidis T, Ainali C, Dafou D, Panteris E, et al. The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling. Cancers (Basel). 2020;12: pubmed publisher
  115. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  116. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  117. Lubos N, van der Gaag S, Gerçek M, Kant S, Leube R, Krusche C. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115:42 pubmed publisher
  118. Kim E, Woodruff M, Grigoryan L, Maier B, Lee S, Mandal P, et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. elife. 2020;9: pubmed publisher
  119. Liao T, Lin C, Jiang J, Yang S, Teng H, Yang M. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer. Theranostics. 2020;10:6095-6112 pubmed publisher
  120. Witschen P, Chaffee T, Brady N, Huggins D, Knutson T, LaRue R, et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers (Basel). 2020;12: pubmed publisher
  121. Castiello M, Bosticardo M, Sacchetti N, Calzoni E, Fontana E, Yamazaki Y, et al. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency. J Allergy Clin Immunol. 2021;147:309-320.e6 pubmed publisher
  122. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  123. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  124. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  125. Zhu M, Ma Y, Tan K, Zhang L, Wang Z, Li Y, et al. Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts. BMC Immunol. 2020;21:19 pubmed publisher
  126. Luoni M, Giannelli S, Indrigo M, Niro A, Massimino L, Iannielli A, et al. Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome. elife. 2020;9: pubmed publisher
  127. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  128. Álvarez Salamero C, Castillo González R, Pastor Fernández G, Mariblanca I, Pino J, Cibrian D, et al. IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics. PLoS Biol. 2020;18:e3000646 pubmed publisher
  129. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  130. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  131. Aaltonen N, Singha P, Jakupović H, Wirth T, Samaranayake H, Pasonen Seppänen S, et al. High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections - Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils. Biol Proced Online. 2020;22:6 pubmed publisher
  132. Zhang S, Liang W, Luo L, Sun S, Wang F. The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology. BMC Biol. 2020;18:29 pubmed publisher
  133. Donaldson D, Bradford B, Else K, Mabbott N. Accelerated onset of CNS prion disease in mice co-infected with a gastrointestinal helminth pathogen during the preclinical phase. Sci Rep. 2020;10:4554 pubmed publisher
  134. Ramstead A, Wallace J, Lee S, Bauer K, Tang W, Ekiz H, et al. Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development. Cell Rep. 2020;30:2889-2899.e6 pubmed publisher
  135. Kumar A, Chamoto K, Chowdhury P, Honjo T. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy. elife. 2020;9: pubmed publisher
  136. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  137. Wei J, Mattapallil M, Horai R, Jittayasothorn Y, Modi A, Sen H, et al. A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. elife. 2020;9: pubmed publisher
  138. Martens R, Permanyer M, Werth K, Yu K, Braun A, Halle O, et al. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. Nat Commun. 2020;11:1114 pubmed publisher
  139. Jiang M, Bi X, Duan X, Pang N, Wang H, Yuan H, et al. Adipose tissue-derived stem cells modulate immune function in vivo and promote long-term hematopoiesis in vitro using the aGVHD model. Exp Ther Med. 2020;19:1725-1732 pubmed publisher
  140. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  141. Angenendt A, Steiner R, Knörck A, Schwär G, Konrad M, Krause E, et al. Orai, STIM, and PMCA contribute to reduced calcium signal generation in CD8+ T cells of elderly mice. Aging (Albany NY). 2020;12:3266-3286 pubmed publisher
  142. Lee J, Zhang J, Chung Y, Kim J, Kook C, Gonzalez Navajas J, et al. Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses. elife. 2020;9: pubmed publisher
  143. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed publisher
  144. Bell O, Copland D, Ward A, Nicholson L, Lange C, Chu C, et al. Single Eye mRNA-Seq Reveals Normalisation of the Retinal Microglial Transcriptome Following Acute Inflammation. Front Immunol. 2019;10:3033 pubmed publisher
  145. Tan G, Pryce B, Stabio A, Brigande J, Wang C, Xia Z, et al. Tgfβ signaling is critical for maintenance of the tendon cell fate. elife. 2020;9: pubmed publisher
  146. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  147. Kim J, Fei L, Yin W, Coquenlorge S, Rao Bhatia A, Zhang X, et al. Single cell and genetic analyses reveal conserved populations and signaling mechanisms of gastrointestinal stromal niches. Nat Commun. 2020;11:334 pubmed publisher
  148. Blagih J, Zani F, Chakravarty P, Hennequart M, Pilley S, Hobor S, et al. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses. Cell Rep. 2020;30:481-496.e6 pubmed publisher
  149. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  150. Liu Q, Zhou C, Zhang B. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. BMC Gastroenterol. 2019;19:230 pubmed publisher
  151. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  152. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  153. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  154. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  155. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  156. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  157. Wang Y, Chiang I, Ohara T, Fujii S, Cheng J, Muegge B, et al. Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem Cells. Cell. 2019;179:1144-1159.e15 pubmed publisher
  158. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  159. Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R, et al. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019;18:156 pubmed publisher
  160. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  161. Mani V, Bromley S, Aijö T, Mora Buch R, Carrizosa E, Warner R, et al. Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science. 2019;366: pubmed publisher
  162. Shikama Y, Kurosawa M, Furukawa M, Ishimaru N, Matsushita K. Involvement of adiponectin in age-related increases in tear production in mice. Aging (Albany NY). 2019;11:8329-8346 pubmed publisher
  163. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  164. Nelson C, Thompson E, Quarnstrom C, Fraser K, Seelig D, Bhela S, et al. Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens. Cell Rep. 2019;28:3092-3104.e5 pubmed publisher
  165. Noguerol J, Roustan P, N Taye M, Delcombel L, Rolland C, Guiraud L, et al. Sexual dimorphism in PAR2-dependent regulation of primitive colonic cells. Biol Sex Differ. 2019;10:47 pubmed publisher
  166. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  167. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  168. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  169. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  170. Benci J, Johnson L, Choa R, Xu Y, Qiu J, Zhou Z, et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178:933-948.e14 pubmed publisher
  171. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  172. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed publisher
  173. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  174. Wolock S, Krishnan I, Tenen D, Matkins V, Camacho V, Patel S, et al. Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths. Cell Rep. 2019;28:302-311.e5 pubmed publisher
  175. Xie X, Wang Y, Xia Y, Mao Y. Overexpressed vascular endothelial growth factor in adipose derived stem cells attenuates fibroblasts and skin injuries by ultraviolet radiation. Biosci Rep. 2019;39: pubmed publisher
  176. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  177. Khanom U, Ohigashi I, Fujimori S, Kondo K, Takada K, Takahama Y. TCR Affinity for In Vivo Peptide-Induced Thymic Positive Selection Fine-Tunes TCR Responsiveness of Peripheral CD8+ T Cells. J Immunol. 2019;: pubmed publisher
  178. Leach S, Shinnakasu R, Adachi Y, Momota M, Makino Okamura C, Yamamoto T, et al. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. Int Immunol. 2019;: pubmed publisher
  179. Ansaldo E, Slayden L, Ching K, Koch M, Wolf N, Plichta D, et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364:1179-1184 pubmed publisher
  180. Khan O, Giles J, McDonald S, Manne S, Ngiow S, Patel K, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;: pubmed publisher
  181. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  182. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  183. von Gamm M, Schaub A, Jones A, Wolf C, Behrens G, Lichti J, et al. Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3. J Exp Med. 2019;: pubmed publisher
  184. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  185. Atif S, Mack D, McKee A, Rangel Moreno J, Martin A, Getahun A, et al. Protective role of B cells in sterile particulate-induced lung injury. JCI Insight. 2019;5: pubmed publisher
  186. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  187. Guiu J, Hannezo E, Yui S, Demharter S, Ulyanchenko S, Maimets M, et al. Tracing the origin of adult intestinal stem cells. Nature. 2019;570:107-111 pubmed publisher
  188. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  189. Choi J, Zhong X, McAlpine W, Liao T, Zhang D, Fang B, et al. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science. 2019;364: pubmed publisher
  190. Kotov J, Kotov D, Linehan J, Bardwell V, Gearhart M, Jenkins M. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med. 2019;216:1450-1464 pubmed publisher
  191. Maji B, Gangopadhyay S, Lee M, Shi M, Wu P, Heler R, et al. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9. Cell. 2019;177:1067-1079.e19 pubmed publisher
  192. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  193. Lu D, Liao Y, Zhu S, Chen Q, Xie D, Liao J, et al. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction. Stem Cell Res Ther. 2019;10:127 pubmed publisher
  194. Ahmed M, El Sayed A, Chen H, Zhao R, Yusuf M, Zuo Q, et al. Comparison between curcumin and all-trans retinoic acid in the osteogenic differentiation of mouse bone marrow mesenchymal stem cells. Exp Ther Med. 2019;17:4154-4166 pubmed publisher
  195. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  196. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  197. Pais H, Ruggero K, Zhang J, Al Assar O, Bery N, Bhuller R, et al. Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Sci Rep. 2019;9:5760 pubmed publisher
  198. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  199. Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
  200. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  201. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed publisher
  202. Sinclair L, Howden A, Brenes A, Spinelli L, Hukelmann J, Macintyre A, et al. Antigen receptor control of methionine metabolism in T cells. elife. 2019;8: pubmed publisher
  203. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  204. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  205. Johansson J, Nászai M, Hodder M, Pickering K, Miller B, Ridgway R, et al. RAL GTPases Drive Intestinal Stem Cell Function and Regeneration through Internalization of WNT Signalosomes. Cell Stem Cell. 2019;24:592-607.e7 pubmed publisher
  206. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  207. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  208. Han Y, Feng H, Sun J, Liang X, Wang Z, Xing W, et al. Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation. J Clin Invest. 2019;130: pubmed publisher
  209. Schulien I, Hockenjos B, Schmitt Graeff A, Perdekamp M, Follo M, Thimme R, et al. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. Cell Death Differ. 2019;: pubmed publisher
  210. Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V, et al. Precise tuning of gene expression levels in mammalian cells. Nat Commun. 2019;10:818 pubmed publisher
  211. Salerno F, Guislain A, Freen van Heeren J, Nicolet B, Young H, Wolkers M. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology. 2019;8:e1532762 pubmed publisher
  212. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  213. Yamamoto T, Lee P, Vodnala S, Gurusamy D, Kishton R, Yu Z, et al. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019;129:1551-1565 pubmed publisher
  214. Faliti C, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216:317-336 pubmed publisher
  215. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  216. Li J, He Y, Hao J, Ni L, Dong C. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells. Front Immunol. 2018;9:2981 pubmed publisher
  217. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  218. Zhang C, Wang Y. Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway. Mol Med Rep. 2019;19:1203-1209 pubmed publisher
  219. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  220. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  221. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  222. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  223. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  224. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  225. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  226. Gejman R, Chang A, Jones H, DiKun K, Hakimi A, Schietinger A, et al. Rejection of immunogenic tumor clones is limited by clonal fraction. elife. 2018;7: pubmed publisher
  227. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  228. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  229. Dong S, Harrington B, Hu E, Greene J, Lehman A, Tran M, et al. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression. J Clin Invest. 2019;129:122-136 pubmed publisher
  230. Ng K, Yui M, Mehta A, Siu S, Irwin B, Pease S, et al. A stochastic epigenetic switch controls the dynamics of T-cell lineage commitment. elife. 2018;7: pubmed publisher
  231. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  232. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  233. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher
  234. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed publisher
  235. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  236. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  237. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  238. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  239. Qiao G, Bucsek M, Winder N, Chen M, Giridharan T, Olejniczak S, et al. β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68:11-22 pubmed publisher
  240. Giles D, Duncker P, Wilkinson N, Washnock Schmid J, Segal B. CNS-resident classical DCs play a critical role in CNS autoimmune disease. J Clin Invest. 2018;128:5322-5334 pubmed publisher
  241. Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380-1391 pubmed publisher
  242. Kim A, Lee E, Lee E, Kim J, Suk K, Lee E, et al. SIRT2 is required for efficient reprogramming of mouse embryonic fibroblasts toward pluripotency. Cell Death Dis. 2018;9:893 pubmed publisher
  243. Leng Y, Abdullah A, Wendt M, Calve S. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis. Matrix Biol. 2019;78-79:236-254 pubmed publisher
  244. Cummings M, Arumanayagam A, Zhao P, Kannanganat S, Stuve O, Karandikar N, et al. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 2018;13:e0200752 pubmed publisher
  245. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  246. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  247. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  248. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  249. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  250. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  251. Li J, Byrne K, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. 2018;49:178-193.e7 pubmed publisher
  252. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  253. Nusse Y, Savage A, Marangoni P, Rosendahl Huber A, Landman T, De Sauvage F, et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature. 2018;559:109-113 pubmed publisher
  254. Kirkling M, Cytlak U, Lau C, Lewis K, Resteu A, Khodadadi Jamayran A, et al. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep. 2018;23:3658-3672.e6 pubmed publisher
  255. Huang W, Bei L, Eklund E. Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin. Oncotarget. 2018;9:25891-25902 pubmed publisher
  256. Feng Y, Liao Y, Huang W, Lai X, Luo J, Du C, et al. Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis. Cell Death Dis. 2018;9:691 pubmed publisher
  257. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  258. Noguchi N, Nakamura R, Hatano S, Yamada H, Sun X, Ohara N, et al. Interleukin-21 Induces Short-Lived Effector CD8+ T Cells but Does Not Inhibit Their Exhaustion after Mycobacterium bovis BCG Infection in Mice. Infect Immun. 2018;86: pubmed publisher
  259. Chen Y, Qin X, An Q, Yi J, Feng F, Yin D, et al. Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes. EBioMedicine. 2018;32:31-42 pubmed publisher
  260. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  261. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  262. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  263. Stefani F, Eberstål S, Vergani S, Kristiansen T, Bengzon J. Low-dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo. Int J Cancer. 2018;143:2200-2212 pubmed publisher
  264. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  265. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  266. Ge J, Burnier L, Adamopoulou M, Kwa M, Schaks M, Rottner K, et al. RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells. J Biol Chem. 2018;293:9358-9369 pubmed publisher
  267. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  268. Dipiazza A, Laniewski N, Rattan A, Topham D, Miller J, Sant A. CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J Virol. 2018;92: pubmed publisher
  269. Tanaka S, Pfleger C, Lai J, Roan F, Sun S, Ziegler S. KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep. 2018;23:796-807 pubmed publisher
  270. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed publisher
  271. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  272. Zhang D, Wu J, Shah B, Greutélaers K, Ghosh M, Ollivierre H, et al. Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk. Science. 2018;359:1520-1523 pubmed publisher
  273. Zhang Y, Tech L, George L, Acs A, Durrett R, Hess H, et al. Plasma cell output from germinal centers is regulated by signals from Tfh and stromal cells. J Exp Med. 2018;215:1227-1243 pubmed publisher
  274. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed publisher
  275. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  276. Khan A, Carpenter B, Santos e Sousa P, Pospori C, Khorshed R, Griffin J, et al. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024 pubmed publisher
  277. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  278. Kotov D, Kotov J, Goldberg M, Jenkins M. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol. 2018;200:2004-2012 pubmed publisher
  279. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed publisher
  280. Jung Y, Cackowski F, Yumoto K, Decker A, Wang J, Kim J, et al. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Res. 2018;78:2026-2039 pubmed publisher
  281. Chen X, Nagai Y, Zhu Z, Ruan H, Peehl D, Greene M, et al. A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77. Oncotarget. 2018;9:3631-3640 pubmed publisher
  282. Ellestad K, Thangavelu G, Haile Y, Lin J, Boon L, Anderson C. Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1. Front Immunol. 2018;9:12 pubmed publisher
  283. Ehlers L, Rohde S, Ibrahim S, Jaster R. Adoptive transfer of CD3+ T cells and CD4+ CD44high memory T cells induces autoimmune pancreatitis in MRL/MpJ mice. J Cell Mol Med. 2018;22:2404-2412 pubmed publisher
  284. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  285. Solomon H, Dinowitz N, Pateras I, Cooks T, Shetzer Y, Molchadsky A, et al. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene. 2018;37:1669-1684 pubmed publisher
  286. Koh A, Miller E, Buenrostro J, Moskowitz D, Wang J, Greenleaf W, et al. Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol. 2018;19:162-172 pubmed publisher
  287. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  288. Freeman S, Vega A, Riedl M, Collins R, Ostrowski P, Woods E, et al. Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement. Cell. 2018;172:305-317.e10 pubmed publisher
  289. Kaufmann E, Sanz J, Dunn J, Khan N, Mendonça L, Pacis A, et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell. 2018;172:176-190.e19 pubmed publisher
  290. Nakashima H, Alayo Q, Penaloza MacMaster P, Freeman G, Kuchroo V, Reardon D, et al. Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells. Sci Rep. 2018;8:208 pubmed publisher
  291. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  292. Ibitokou S, Dillon B, Sinha M, Szczesny B, Delgadillo A, Reda Abdelrahman D, et al. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection. J Immunol. 2018;200:643-656 pubmed publisher
  293. Ibrahim M, Scozzi D, Toth K, Ponti D, Kreisel D, Menna C, et al. Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion. J Immunol. 2018;200:847-856 pubmed publisher
  294. Iseka F, Goetz B, Mushtaq I, An W, Cypher L, Bielecki T, et al. Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol. 2018;200:483-499 pubmed publisher
  295. Zhao B, Mei Y, Cao L, Zhang J, Sumagin R, Yang J, et al. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest. 2018;128:125-140 pubmed publisher
  296. Ruetz T, Pfisterer U, Di Stefano B, Ashmore J, Beniazza M, Tian T, et al. Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming. Cell Stem Cell. 2017;21:791-805.e9 pubmed publisher
  297. Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord J, Pongracz J, et al. PPARgamma Deficiency Counteracts Thymic Senescence. Front Immunol. 2017;8:1515 pubmed publisher
  298. Robles Valero J, Lorenzo Martín L, Menacho Márquez M, Fernández Pisonero I, Abad A, Camos M, et al. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2017;32:608-623.e9 pubmed publisher
  299. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  300. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  301. Francis N, Every A, Ayodele B, Pike R, Mackie E, Pagel C. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. Int J Biochem Cell Biol. 2017;92:95-103 pubmed publisher
  302. Blanchfield L, Sabatino J, Lawrence L, Evavold B. NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease. J Immunol. 2017;199:2680-2691 pubmed publisher
  303. Jin L, Vu T, Yuan G, Datta P. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway. Cancer Res. 2017;77:5464-5478 pubmed publisher
  304. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  305. Li L, Labuda J, Imai D, Griffey S, McSorley S. CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract. J Immunol. 2017;199:2547-2554 pubmed publisher
  306. Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang Y, et al. The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep. 2017;20:600-612 pubmed publisher
  307. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  308. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  309. Sitrin J, Suto E, Wuster A, Eastham Anderson J, Kim J, Austin C, et al. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. J Immunol. 2017;199:1238-1249 pubmed publisher
  310. Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 2017;24:1739-1749 pubmed publisher
  311. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed publisher
  312. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed publisher
  313. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  314. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  315. Miyazaki M, Miyazaki K, Chen K, Jin Y, Turner J, Moore A, et al. The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development. Immunity. 2017;46:818-834.e4 pubmed publisher
  316. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  317. Torcellan T, Hampton H, Bailey J, Tomura M, Brink R, Chtanova T. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci U S A. 2017;114:5677-5682 pubmed publisher
  318. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  319. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  320. Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
  321. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  322. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  323. Lu P, Shih C, Qi H. Ephrin B1-mediated repulsion and signaling control germinal center T cell territoriality and function. Science. 2017;356: pubmed publisher
  324. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  325. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  326. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  327. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  328. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  329. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  330. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  331. Sosunov A, McKhann G, Goldman J. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathol Commun. 2017;5:27 pubmed publisher
  332. Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed publisher
  333. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  334. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  335. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  336. Patouraux S, Rousseau D, Bonnafous S, Lebeaupin C, Luci C, Canivet C, et al. CD44 is a key player in non-alcoholic steatohepatitis. J Hepatol. 2017;67:328-338 pubmed publisher
  337. Clark K, Fierro F, Ko E, Walker N, Arzi B, Tepper C, et al. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther. 2017;8:69 pubmed publisher
  338. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  339. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  340. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  341. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  342. Okada T, Ogura T. High-resolution imaging of living mammalian cells bound by nanobeads-connected antibodies in a medium using scanning electron-assisted dielectric microscopy. Sci Rep. 2017;7:43025 pubmed publisher
  343. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  344. Horvatinovich J, Grogan E, Norris M, Steinkasserer A, Lemos H, Mellor A, et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes. J Immunol. 2017;198:2286-2301 pubmed publisher
  345. Fernandez N, Renna H, McHugh L, Mazolkova K, Crugnola W, Evans J. Mouse Mesenchymal Progenitor Cells Expressing Adipogenic and Osteogenic Transcription Factors Suppress the Macrophage Inflammatory Response. Stem Cells Int. 2017;2017:5846257 pubmed publisher
  346. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  347. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  348. Ritschka B, Storer M, Mas A, Heinzmann F, Ortells M, Morton J, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31:172-183 pubmed publisher
  349. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  350. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  351. Pal D, Pertot A, Shirole N, Yao Z, Anaparthy N, Garvin T, et al. TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells. elife. 2017;6: pubmed publisher
  352. Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7:40273 pubmed publisher
  353. Jiang X, Park C, Geddes Sweeney J, Yoo M, Gaide O, Kupper T. Dermal ?? T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity. PLoS ONE. 2017;12:e0169397 pubmed publisher
  354. Rampoldi F, Brunk F, Bonrouhi M, Federico G, Krunic D, Porubsky S, et al. Deficiency of N-myristoylation reveals calcineurin activity as regulator of IFN-?-producing ?? T cells. J Leukoc Biol. 2017;101:1005-1014 pubmed publisher
  355. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed publisher
  356. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  357. Marshall N, Vong A, Devarajan P, Brauner M, Kuang Y, Nayar R, et al. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol. 2017;198:1142-1155 pubmed publisher
  358. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  359. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  360. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  361. Jerić I, Maurer G, Cavallo A, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7:13781 pubmed publisher
  362. Beyaz S, Kim J, Pinello L, Xifaras M, Hu Y, Huang J, et al. The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells. Nat Immunol. 2017;18:184-195 pubmed publisher
  363. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  364. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  365. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed publisher
  366. Jacobsen E, Ochkur S, Doyle A, Lesuer W, Li W, Protheroe C, et al. Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation. Am J Respir Crit Care Med. 2017;195:1321-1332 pubmed publisher
  367. Monfared M, Minaee B, Rastegar T, Khrazinejad E, Barbarestani M. Sertoli cell condition medium can induce germ like cells from bone marrow derived mesenchymal stem cells. Iran J Basic Med Sci. 2016;19:1186-1192 pubmed
  368. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  369. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  370. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  371. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  372. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed publisher
  373. Martínez Gómez J, Periasamy P, Dutertre C, Irving A, Ng J, Crameri G, et al. Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto. Sci Rep. 2016;6:37796 pubmed publisher
  374. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  375. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  376. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  377. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  378. Shatirishvili M, Burk A, Franz C, Pace G, Kastilan T, Breuhahn K, et al. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress. Cell Death Dis. 2016;7:e2461 pubmed publisher
  379. Brocks T, Fedorchenko O, Schliermann N, Stein A, Moll U, Seegobin S, et al. Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin. FASEB J. 2017;31:526-543 pubmed publisher
  380. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  381. Laurent C, Dorothee G, Hunot S, Martin E, Monnet Y, Duchamp M, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain. 2017;140:184-200 pubmed publisher
  382. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  383. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  384. Swartz K, Wood S, Murthy T, Ramirez O, Qin G, Pillai M, et al. E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts. Mol Cell Biol. 2017;37: pubmed publisher
  385. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  386. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  387. Kwong Chung C, Ronchi F, Geuking M. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology. 2017;150:221-235 pubmed publisher
  388. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  389. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  390. Alves da Costa T, Di Gangi R, Thomé R, Barreto Felisbino M, Pires Bonfanti A, Lumi Watanabe Ishikawa L, et al. Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis. PLoS ONE. 2016;11:e0164745 pubmed publisher
  391. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  392. Case A, Roessner C, Tian J, Zimmerman M. Mitochondrial Superoxide Signaling Contributes to Norepinephrine-Mediated T-Lymphocyte Cytokine Profiles. PLoS ONE. 2016;11:e0164609 pubmed publisher
  393. Liu Z, Tian R, Li Y, Zhang L, Shao H, Yang C, et al. SDF-1?-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci Rep. 2016;6:34416 pubmed publisher
  394. Hiraga T, Nakamura H. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model. Oncol Lett. 2016;12:2962-2969 pubmed
  395. Kang S, Wang Y, Reder N, Liu J. Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry. PLoS ONE. 2016;11:e0163473 pubmed publisher
  396. Rothchild A, Sissons J, Shafiani S, Plaisier C, Min D, Mai D, et al. MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2016;113:E6172-E6181 pubmed
  397. Carnevale D, Perrotta M, Pallante F, Fardella V, Iacobucci R, Fardella S, et al. A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat Commun. 2016;7:13035 pubmed publisher
  398. Urrutia M, Fernandez S, Gonzalez M, Vilches R, Rojas P, Vásquez M, et al. Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels. PLoS ONE. 2016;11:e0163735 pubmed publisher
  399. Lee E, Wang J, Yumoto K, Jung Y, Cackowski F, Decker A, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia. 2016;18:553-66 pubmed publisher
  400. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  401. Kikuchi I, Takahashi Kanemitsu A, Sakiyama N, Tang C, Tang P, Noda S, et al. Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways. Nat Commun. 2016;7:12887 pubmed publisher
  402. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  403. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  404. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  405. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  406. Chai Y, Lee E, Gubbe J, Brekke J. 3D Cell Culture in a Self-Assembled Nanofiber Environment. PLoS ONE. 2016;11:e0162853 pubmed publisher
  407. Liu Z, Chu S, Yao S, Li Y, Fan S, Sun X, et al. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells. Oncotarget. 2016;7:68303-68313 pubmed publisher
  408. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  409. Olofsson P, Steinberg B, Sobbi R, Cox M, Ahmed M, Oswald M, et al. Blood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase. Nat Biotechnol. 2016;34:1066-1071 pubmed publisher
  410. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  411. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  412. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  413. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  414. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  415. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed publisher
  416. Proekt I, Miller C, Jeanne M, Fasano K, Moon J, Lowell C, et al. LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity. J Clin Invest. 2016;126:3758-3771 pubmed publisher
  417. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  418. Ulges A, Witsch E, Pramanik G, Klein M, Birkner K, Bühler U, et al. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development. Proc Natl Acad Sci U S A. 2016;113:10145-50 pubmed publisher
  419. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  420. Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, SCHROEDER J. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. 2016;7:60776-60792 pubmed publisher
  421. Valle Y, Almalki S, Agrawal D. Vitamin D machinery and metabolism in porcine adipose-derived mesenchymal stem cells. Stem Cell Res Ther. 2016;7:118 pubmed publisher
  422. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  423. Damgaard R, Walker J, Marco Casanova P, Morgan N, Titheradge H, Elliott P, et al. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215-1230.e20 pubmed publisher
  424. Zhang P, He D, Chen Z, Pan Q, Du F, Zang X, et al. Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancer. Biochem Pharmacol. 2016;118:18-30 pubmed publisher
  425. Camilleri E, Gustafson M, Dudakovic A, Riester S, Garces C, Paradise C, et al. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016;7:107 pubmed publisher
  426. Ilmer M, Mazurek N, Byrd J, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7:e2337 pubmed publisher
  427. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  428. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  429. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  430. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  431. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  432. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  433. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed publisher
  434. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  435. Stanly T, Fritzsche M, Banerji S, Garcia E, Bernardino de la Serna J, Jackson D, et al. Critical importance of appropriate fixation conditions for faithful imaging of receptor microclusters. Biol Open. 2016;5:1343-50 pubmed publisher
  436. Di Scala M, Otano I, Gil Farina I, Vanrell L, Hommel M, Olague C, et al. Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. J Virol. 2016;90:8563-74 pubmed publisher
  437. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  438. Parsa R, Lund H, Georgoudaki A, Zhang X, Ortlieb Guerreiro Cacais A, Grommisch D, et al. BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med. 2016;213:1537-53 pubmed publisher
  439. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  440. Drake L, Iijima K, Bartemes K, Kita H. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice. J Immunol. 2016;197:1335-42 pubmed publisher
  441. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  442. Orta Mascaró M, Consuegra Fernández M, Carreras E, Roncagalli R, Carreras Sureda A, Alvarez P, et al. CD6 modulates thymocyte selection and peripheral T cell homeostasis. J Exp Med. 2016;213:1387-97 pubmed publisher
  443. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  444. Ichimaru S, Nakagawa S, Arai Y, Kishida T, Shin Ya M, Honjo K, et al. Hypoxia Potentiates Anabolic Effects of Exogenous Hyaluronic Acid in Rat Articular Cartilage. Int J Mol Sci. 2016;17: pubmed publisher
  445. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  446. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  447. Zhang Y, Cabarcas S, Zheng J, Sun L, Mathews L, Zhang X, et al. Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression. Oncol Lett. 2016;11:3803-3812 pubmed
  448. Nasri I, Bonnet D, Zwarycz B, d Aldebert E, Khou S, Mezghani Jarraya R, et al. PAR2-dependent activation of GSK3? regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol. 2016;311:G221-36 pubmed publisher
  449. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  450. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  451. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  452. Morisaki Y, Niikura M, Watanabe M, Onishi K, Tanabe S, Moriwaki Y, et al. Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9. Sci Rep. 2016;6:27354 pubmed publisher
  453. Lubeseder Martellato C, Hidalgo Sastre A, Hartmann C, Alexandrow K, Kamyabi Moghaddam Z, Sipos B, et al. Membranous CD24 drives the epithelial phenotype of pancreatic cancer. Oncotarget. 2016;7:49156-49168 pubmed publisher
  454. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed publisher
  455. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  456. Patenaude J, Perreault C. Thymic Mesenchymal Cells Have a Distinct Transcriptomic Profile. J Immunol. 2016;196:4760-70 pubmed publisher
  457. Nieves W, Hung L, Oniskey T, Boon L, Foretz M, Viollet B, et al. Myeloid-Restricted AMPK?1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. J Immunol. 2016;196:4632-40 pubmed publisher
  458. Boareto M, Jolly M, Goldman A, Pietila M, Mani S, Sengupta S, et al. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016;13: pubmed publisher
  459. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  460. Wen S, Dooner M, Cheng Y, Papa E, Del Tatto M, Pereira M, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia. 2016;30:2221-2231 pubmed publisher
  461. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  462. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher
  463. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed publisher
  464. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  465. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  466. Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273 pubmed publisher
  467. Verbist K, Guy C, Milasta S, Liedmann S, Kaminski M, Wang R, et al. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature. 2016;532:389-93 pubmed publisher
  468. Holmkvist P, Pool L, Hägerbrand K, Agace W, Rivollier A. IL-18R?-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur J Immunol. 2016;46:1371-82 pubmed publisher
  469. Mall C, Sckisel G, Proia D, Mirsoian A, Grossenbacher S, Pai C, et al. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016;5:e1075114 pubmed
  470. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  471. Jung Y, Decker A, Wang J, Lee E, Kana L, Yumoto K, et al. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow. Oncotarget. 2016;7:25698-711 pubmed publisher
  472. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed publisher
  473. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  474. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  475. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  476. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  477. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  478. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  479. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  480. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  481. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  482. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  483. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  484. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed publisher
  485. Li X, Wu J, Li Q, Shigemura K, Chung L, Huang W. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget. 2016;7:12869-84 pubmed publisher
  486. Gehlot P, Shukla V, Gupta S, Makidon P. Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells. J Transl Med. 2016;14:49 pubmed publisher
  487. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  488. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  489. Vieyra Garcia P, Wei T, Naym D, Fredholm S, Fink Puches R, Cerroni L, et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res. 2016;22:3328-39 pubmed publisher
  490. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  491. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  492. Tubo N, Fife B, Pagán A, Kotov D, Goldberg M, Jenkins M. Most microbe-specific naïve CD4? T cells produce memory cells during infection. Science. 2016;351:511-4 pubmed publisher
  493. Atkinson S, Hoffmann U, Hamann A, Bach E, Danneskiold Samsøe N, Kristiansen K, et al. Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade. Dis Model Mech. 2016;9:427-40 pubmed publisher
  494. Thornton T, Delgado P, Chen L, Salas B, Krementsov D, Fernández M, et al. Inactivation of nuclear GSK3β by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response. Nat Commun. 2016;7:10553 pubmed publisher
  495. Lee B, Koo J, Yun Jun J, Gavrilova O, Lee Y, Seo A, et al. A mouse model for a partially inactive obesity-associated human MC3R variant. Nat Commun. 2016;7:10522 pubmed publisher
  496. Aloulou M, Carr E, Gador M, Bignon A, Liblau R, Fazilleau N, et al. Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Nat Commun. 2016;7:10579 pubmed publisher
  497. Masuda T, Wang X, Maeda M, Canver M, Sher F, Funnell A, et al. Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science. 2016;351:285-9 pubmed publisher
  498. Luchsinger L, de Almeida M, Corrigan D, Mumau M, Snoeck H. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential. Nature. 2016;529:528-31 pubmed publisher
  499. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  500. Quattrocelli M, Giacomazzi G, Broeckx S, Ceelen L, Bolca S, Spaas J, et al. Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates. Stem Cell Reports. 2016;6:55-63 pubmed publisher
  501. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  502. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  503. Zhang X, Ma Y, Fu X, Liu Q, Shao Z, Dai L, et al. Runx2-Modified Adipose-Derived Stem Cells Promote Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction. Sci Rep. 2016;6:19073 pubmed publisher
  504. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  505. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  506. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  507. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  508. Cheung S, Chuang P, Huang H, Hwang Verslues W, Cho C, Yang W, et al. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A. 2016;113:960-5 pubmed publisher
  509. Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5:18099 pubmed publisher
  510. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  511. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  512. Lindemans C, Calafiore M, Mertelsmann A, O Connor M, Dudakov J, Jenq R, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528:560-564 pubmed publisher
  513. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  514. Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed publisher
  515. Gururajan M, Cavassani K, Sievert M, Duan P, Lichterman J, Huang J, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. 2015;6:44072-83 pubmed publisher
  516. Assayag Asherie N, Sever D, Bogdani M, Johnson P, Weiss T, Ginzberg A, et al. Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes. PLoS ONE. 2015;10:e0143589 pubmed publisher
  517. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  518. Abe S, Yamaguchi S, Sato Y, Harada K. Sphere-Derived Multipotent Progenitor Cells Obtained From Human Oral Mucosa Are Enriched in Neural Crest Cells. Stem Cells Transl Med. 2016;5:117-28 pubmed publisher
  519. Arzi B, Mills Ko E, Verstraete F, Kol A, Walker N, Badgley M, et al. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2016;5:75-86 pubmed publisher
  520. Hu Y, Zhang Y, Tian K, Xun C, Wang S, Lv D. Effects of nerve growth factor and basic fibroblast growth factor dual gene modification on rat bone marrow mesenchymal stem cell differentiation into neuron-like cells in vitro. Mol Med Rep. 2016;13:49-58 pubmed publisher
  521. Pai P, Rachagani S, Lakshmanan I, Macha M, Sheinin Y, Smith L, et al. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol. 2016;10:224-39 pubmed publisher
  522. Parys M, Nelson N, Koehl K, Miller R, Kaneene J, Kruger J, et al. Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats. J Vet Intern Med. 2016;30:157-63 pubmed publisher
  523. Oh Y, Park H, Shin J, Lee J, Park H, Kho D, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698 pubmed publisher
  524. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  525. Ruan S, Samuelson D, Assouline B, Morre M, Shellito J. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice. Infect Immun. 2016;84:108-19 pubmed publisher
  526. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  527. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  528. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  529. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  530. Forni M, Ramos Maia Lobba A, Pereira Ferreira A, Sogayar M. Simultaneous Isolation of Three Different Stem Cell Populations from Murine Skin. PLoS ONE. 2015;10:e0140143 pubmed publisher
  531. Yun J, Song S, Kang J, Park J, Kim H, Han S, et al. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability. Nucleic Acids Res. 2016;44:558-72 pubmed publisher
  532. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed publisher
  533. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed publisher
  534. McCormack R, de Armas L, Shiratsuchi M, Fiorentino D, Olsson M, Lichtenheld M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. elife. 2015;4: pubmed publisher
  535. Wei T, Zhang N, Guo Z, Chi F, Song Y, Zhu X. Wnt4 signaling is associated with the decrease of proliferation and increase of apoptosis during age-related thymic involution. Mol Med Rep. 2015;12:7568-76 pubmed publisher
  536. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed publisher
  537. Lynskey N, Banerji S, Johnson L, Holder K, Reglinski M, Wing P, et al. Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction. PLoS Pathog. 2015;11:e1005137 pubmed publisher
  538. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  539. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  540. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  541. Sawitza I, Kordes C, Götze S, Herebian D, Häussinger D. Bile acids induce hepatic differentiation of mesenchymal stem cells. Sci Rep. 2015;5:13320 pubmed publisher
  542. Manieri N, Mack M, Himmelrich M, Worthley D, Hanson E, Eckmann L, et al. Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis. J Clin Invest. 2015;125:3606-18 pubmed publisher
  543. Chantzoura E, Skylaki S, Menendez S, Kim S, Johnsson A, Linnarsson S, et al. Reprogramming Roadblocks Are System Dependent. Stem Cell Reports. 2015;5:350-64 pubmed publisher
  544. Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86 pubmed
  545. Choi Y, Gullicksrud J, Xing S, Zeng Z, Shan Q, Li F, et al. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol. 2015;16:980-90 pubmed publisher
  546. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  547. Kaminsky L, Sei J, Parekh N, Davies M, Reider I, Krouse T, et al. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection. J Virol. 2015;89:9974-85 pubmed publisher
  548. Riordan D, Varma S, West R, Brown P. Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling. PLoS ONE. 2015;10:e0128975 pubmed publisher
  549. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  550. de Carvalho J, Zonari A, de Paula A, Martins T, Gomes D, Goes A. Production of Human Endothelial Cells Free from Soluble Xenogeneic Antigens for Bioartificial Small Diameter Vascular Graft Endothelization. Biomed Res Int. 2015;2015:652474 pubmed publisher
  551. Liang Y, Hu J, Li J, Liu Y, Yu J, Zhuang X, et al. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer. Cancer Res. 2015;75:3672-80 pubmed publisher
  552. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  553. Ackerknecht M, Hauser M, Legler D, Stein J. In vivo TCR Signaling in CD4(+) T Cells Imprints a Cell-Intrinsic, Transient Low-Motility Pattern Independent of Chemokine Receptor Expression Levels, or Microtubular Network, Integrin, and Protein Kinase C Activity. Front Immunol. 2015;6:297 pubmed publisher
  554. Kamimura D, Katsunuma K, Arima Y, Atsumi T, Jiang J, Bando H, et al. KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun. 2015;6:7474 pubmed publisher
  555. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  556. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration. PLoS ONE. 2015;10:e0128094 pubmed publisher
  557. Song H, Wang H, Wu W, Qi L, Shao L, Wang F, et al. Inhibitory role of reactive oxygen species in the differentiation of multipotent vascular stem cells into vascular smooth muscle cells in rats: a novel aspect of traditional culture of rat aortic smooth muscle cells. Cell Tissue Res. 2015;362:97-113 pubmed publisher
  558. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  559. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  560. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  561. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  562. Liang X, Ding Y, Zhang Y, Chai Y, He J, Chiu S, et al. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 2015;6:e1765 pubmed publisher
  563. Seo K, Lee S, Ye B, Kim Y, Bae S, Kim C. Mechanical stretch enhances the expression and activity of osteopontin and MMP-2 via the Akt1/AP-1 pathways in VSMC. J Mol Cell Cardiol. 2015;85:13-24 pubmed publisher
  564. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  565. Kahra D, Mondol T, Niemiec M, Wittung Stafshede P. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro. Protein Pept Lett. 2015;22:532-8 pubmed
  566. Zhou F, Gao S, Wang L, Sun C, Chen L, Yuan P, et al. Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model. Stem Cell Res Ther. 2015;6:92 pubmed publisher
  567. Sadowski S, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, et al. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Oncotarget. 2015;6:18038-49 pubmed
  568. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  569. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  570. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed publisher
  571. Pei B, Zhao M, Miller B, Véla J, Bruinsma M, Virgin H, et al. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation. J Immunol. 2015;194:5872-84 pubmed publisher
  572. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  573. Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:6970 pubmed publisher
  574. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  575. Evans J, Salvador V, George S, Trevino Gutierrez C, Nunez C. Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions. Stem Cell Res Ther. 2015;6:56 pubmed publisher
  576. ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
  577. Meidhof S, Brabletz S, Lehmann W, Preca B, Mock K, Ruh M, et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med. 2015;7:831-47 pubmed publisher
  578. Boding L, Hansen A, Nielsen M, Meroni G, Braunstein T, Woetmann A, et al. Midline 1 controls polarization and migration of murine cytotoxic T cells. Immun Inflamm Dis. 2014;2:262-71 pubmed publisher
  579. Hayashi Y, Bardsley M, Toyomasu Y, Milosavljevic S, Gajdos G, Choi K, et al. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1. Gastroenterology. 2015;149:420-32.e16 pubmed publisher
  580. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed publisher
  581. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7:754-69 pubmed publisher
  582. Ali H, Al Yatama M, Abu Farha M, Behbehani K, Al Madhoun A. Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS ONE. 2015;10:e0122465 pubmed publisher
  583. Lujan E, Zunder E, Ng Y, Goronzy I, Nolan G, Wernig M. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352-6 pubmed publisher
  584. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  585. Yang Y, Gomez J, Herrera M, Perez Marco R, Repenning P, Zhang Z, et al. Salt restriction leads to activation of adult renal mesenchymal stromal cell-like cells via prostaglandin E2 and E-prostanoid receptor 4. Hypertension. 2015;65:1047-54 pubmed publisher
  586. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  587. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  588. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  589. Yang H, Ma Y, Zhou Y, Xu L, Chen X, Ding W, et al. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Cancer Lett. 2015;361:128-36 pubmed publisher
  590. Pratama A, Srivastava M, Williams N, Papa I, Lee S, Dinh X, et al. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436 pubmed publisher
  591. Costabile V, Duraturo F, Delrio P, Rega D, Pace U, Liccardo R, et al. Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures. Int J Oncol. 2015;46:1913-23 pubmed publisher
  592. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  593. Srivastava M, Duan G, Kershaw N, Athanasopoulos V, Yeo J, Ose T, et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat Commun. 2015;6:6253 pubmed publisher
  594. Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y, et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353 pubmed publisher
  595. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  596. Gong J, Weng D, Eguchi T, Murshid A, Sherman M, Song B, et al. Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis. Oncogene. 2015;34:5460-71 pubmed publisher
  597. Buchwald Z, Yang C, Nellore S, Shashkova E, Davis J, Cline A, et al. A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells. J Bone Miner Res. 2015;30:1508-22 pubmed publisher
  598. Hartmann M, Parra L, Ruschel A, Böhme S, Li Y, Morrison H, et al. Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44. Mol Cancer Res. 2015;13:879-90 pubmed publisher
  599. Michelet X, Garg S, Wolf B, Tuli A, Ricciardi Castagnoli P, Brenner M. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b. J Immunol. 2015;194:2079-88 pubmed publisher
  600. Urness L, Wang X, Shibata S, Ohyama T, Mansour S. Fgf10 is required for specification of non-sensory regions of the cochlear epithelium. Dev Biol. 2015;400:59-71 pubmed publisher
  601. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  602. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  603. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  604. Zhang Y, Wu B, Metelli A, Thaxton J, Hong F, Rachidi S, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125:859-69 pubmed publisher
  605. Schumacher M, Aihara E, Feng R, Engevik A, Shroyer N, Ottemann K, et al. The use of murine-derived fundic organoids in studies of gastric physiology. J Physiol. 2015;593:1809-27 pubmed publisher
  606. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  607. Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep. 2015;5:7767 pubmed publisher
  608. Long P, Tighe S, Driscoll H, Fortner K, Viapiano M, Jaworski D. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. J Cell Physiol. 2015;230:1929-43 pubmed publisher
  609. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  610. Singh S, Nehete P, Yang G, He H, Nehete B, Hanley P, et al. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines (Basel). 2014;2:686-706 pubmed publisher
  611. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed publisher
  612. Mouraret N, Houssaïni A, Abid S, Quarck R, Marcos E, Parpaleix A, et al. Role for telomerase in pulmonary hypertension. Circulation. 2015;131:742-755 pubmed publisher
  613. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  614. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  615. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  616. Dong X, Lin Q, Aihara A, Li Y, Huang C, Chung W, et al. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget. 2015;6:1231-48 pubmed
  617. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  618. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  619. Ohmura M, Hishiki T, Yamamoto T, Nakanishi T, Kubo A, Tsuchihashi K, et al. Impacts of CD44 knockdown in cancer cells on tumor and host metabolic systems revealed by quantitative imaging mass spectrometry. Nitric Oxide. 2015;46:102-13 pubmed publisher
  620. Guo X, Tanaka Y, Kondo M. Thymic precursors of TCRαβ(+)CD8αα(+) intraepithelial lymphocytes are negative for CD103. Immunol Lett. 2015;163:40-8 pubmed publisher
  621. Martin P, Dubois C, Jacquier E, Dion S, Mancini Bourgine M, Godon O, et al. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice. Gut. 2015;64:1961-71 pubmed publisher
  622. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  623. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  624. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  625. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  626. Ghotra V, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, et al. SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res. 2015;75:230-40 pubmed publisher
  627. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  628. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  629. Acton S, Farrugia A, Astarita J, Mourão Sá D, Jenkins R, Nye E, et al. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature. 2014;514:498-502 pubmed publisher
  630. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed publisher
  631. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  632. Jia D, Yang W, Li L, Liu H, Tan Y, Ooi S, et al. β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ. 2015;22:298-310 pubmed publisher
  633. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  634. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  635. Cao X, Cao D, Jin M, Jia Z, Kong F, Ma H, et al. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach. BMC Gastroenterol. 2014;14:157 pubmed publisher
  636. Carty S, Koretzky G, Jordan M. Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS ONE. 2014;9:e106659 pubmed publisher
  637. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  638. Smith T, Verdeil G, Marquardt K, Sherman L. Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms. J Immunol. 2014;193:3409-16 pubmed publisher
  639. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  640. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  641. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  642. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  643. Bailon E, Ugarte Berzal E, Amigo Jiménez I, Van den Steen P, Opdenakker G, Garcia Marco J, et al. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. J Leukoc Biol. 2014;96:185-99 pubmed publisher
  644. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed publisher
  645. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  646. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed publisher
  647. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  648. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  649. Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive ??T cells in the adult thymus. J Immunol. 2014;193:1204-12 pubmed publisher
  650. Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP/TAZ incorporation in the ?-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157-70 pubmed publisher
  651. Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, et al. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ?ureC::hly vaccine's superior protection against tuberculosis. J Infect Dis. 2014;210:1928-37 pubmed publisher
  652. Zhou Q, Ho A, Schlitzer A, Tang Y, Wong K, Wong F, et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to Blomia tropicalis. J Immunol. 2014;193:496-509 pubmed publisher
  653. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed publisher
  654. Yabas M, Coupland L, Cromer D, Winterberg M, Teoh N, D Rozario J, et al. Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span. J Biol Chem. 2014;289:19531-7 pubmed publisher
  655. Ghazaryan S, Sy C, Hu T, An X, Mohandas N, Fu H, et al. Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation. Mol Cell Biol. 2014;34:2833-47 pubmed publisher
  656. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  657. Mukonoweshuro B, Brown C, Fisher J, Ingham E. Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells. J Tissue Eng. 2014;5:2041731414534255 pubmed publisher
  658. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  659. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  660. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  661. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  662. Harland K, Day E, Apte S, Russ B, Doherty P, Turner S, et al. Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming. Nat Commun. 2014;5:3547 pubmed publisher
  663. Yan J, Villarreal D, Racine T, Chu J, Walters J, Morrow M, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 2014;32:2833-42 pubmed publisher
  664. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  665. Ahmed N, Iu J, Brown C, Taylor D, Kandel R. Serum- and growth-factor-free three-dimensional culture system supports cartilage tissue formation by promoting collagen synthesis via Sox9-Col2a1 interaction. Tissue Eng Part A. 2014;20:2224-33 pubmed publisher
  666. Zhao J, Lin J, Zhu D, Wang X, Brooks D, Chen M, et al. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/?-catenin/BCL9 pathway. Cancer Res. 2014;74:1801-13 pubmed publisher
  667. Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R. Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE. 2014;9:e89885 pubmed publisher
  668. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  669. Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268-80 pubmed publisher
  670. Hirokawa Y, Yip K, Tan C, Burgess A. Colonic myofibroblast cell line stimulates colonoid formation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G547-56 pubmed publisher
  671. Gaughan A, Wang J, Pelletier R, Nadasdy T, Brodsky S, Roy S, et al. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts. Am J Transplant. 2014;14:284-94 pubmed publisher
  672. Torii D, Konishi K, Watanabe N, Goto S, Tsutsui T. Cementogenic potential of multipotential mesenchymal stem cells purified from the human periodontal ligament. Odontology. 2015;103:27-35 pubmed publisher
  673. Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, et al. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant. 2015;24:223-33 pubmed publisher
  674. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  675. Osada M, Singh V, Wu K, Sant Angelo D, Pezzano M. Label retention identifies a multipotent mesenchymal stem cell-like population in the postnatal thymus. PLoS ONE. 2013;8:e83024 pubmed publisher
  676. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  677. Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M, et al. Long-term IKK2/NF-?B signaling in pancreatic ?-cells induces immune-mediated diabetes. Diabetes. 2014;63:960-75 pubmed publisher
  678. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed publisher
  679. Ding Z, Bergman A, Rutemark C, Ouchida R, Ohno H, Wang J, et al. Complement-activating IgM enhances the humoral but not the T cell immune response in mice. PLoS ONE. 2013;8:e81299 pubmed publisher
  680. Meng F, Takaori K, Ito T, Masui T, Kawaguchi M, Kawaguchi Y, et al. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2014;43:7-14 pubmed publisher
  681. Ghazvini M, Sonneveld P, Kremer A, Franken P, Sacchetti A, Atlasi Y, et al. Cancer stemness in Apc- vs. Apc/KRAS-driven intestinal tumorigenesis. PLoS ONE. 2013;8:e73872 pubmed publisher
  682. Wang S, Lee Y, Kim J, Hyun J, Lee K, Kim Y, et al. Potential role of Hedgehog pathway in liver response to radiation. PLoS ONE. 2013;8:e74141 pubmed publisher
  683. Redecke V, Wu R, Zhou J, Finkelstein D, Chaturvedi V, High A, et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods. 2013;10:795-803 pubmed publisher
  684. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-6 pubmed publisher
  685. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  686. Yockey L, Demehri S, Turkoz M, Turkoz A, Ahern P, Jassim O, et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol. 2013;133:2714-2721 pubmed publisher
  687. Tripathi P, Wang Y, Coussens M, Manda K, Casey A, Lin C, et al. Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Oncogene. 2014;33:1840-9 pubmed publisher
  688. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  689. Roehrich M, Spicher A, Milano G, Vassalli G. Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity. Biomed Res Int. 2013;2013:503047 pubmed publisher
  690. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  691. Szabo A, Fong S, Yue L, Zhang K, Strachan L, Scalapino K, et al. The CD44+ ALDH+ population of human keratinocytes is enriched for epidermal stem cells with long-term repopulating ability. Stem Cells. 2013;31:786-99 pubmed publisher
  692. Mathew R, Seiler M, Scanlon S, Mao A, Constantinides M, Bertozzi Villa C, et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. 2012;491:618-21 pubmed publisher
  693. Bonuccelli G, Castello Cros R, Capozza F, Martinez Outschoorn U, Lin Z, Tsirigos A, et al. The milk protein ?-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle. 2012;11:3972-82 pubmed publisher
  694. Yassai M, Cooley B, Gorski J. Developmental dynamics of post-selection thymic DN iNKT. PLoS ONE. 2012;7:e43509 pubmed publisher
  695. Carrier Y, Whitters M, Miyashiro J, LaBranche T, Ramon H, Benoit S, et al. Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells. Eur J Immunol. 2012;42:1393-404 pubmed publisher
  696. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  697. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  698. Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A. 2012;109:7049-54 pubmed publisher
  699. Caserta S, Nausch N, Sawtell A, Drummond R, Barr T, MacDonald A, et al. Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells. PLoS ONE. 2012;7:e35466 pubmed publisher
  700. Stone J, McMillan R, Skaar D, Bradshaw J, Jirtle R, Sikes M. DNA double-strand breaks relieve USF-mediated repression of D?2 germline transcription in developing thymocytes. J Immunol. 2012;188:2266-75 pubmed publisher
  701. Ruckwardt T, Malloy A, Gostick E, Price D, Dash P, McClaren J, et al. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. PLoS Pathog. 2011;7:e1002377 pubmed publisher
  702. Wang R, Xie H, Huang Z, Ma J, Fang X, Ding Y, et al. T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway. J Immunol. 2011;187:5964-73 pubmed publisher
  703. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  704. Shameli A, Clemente Casares X, Wang J, Santamaria P. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent. J Immunol. 2011;187:2859-66 pubmed publisher
  705. Zaragoza B, Evaristo C, Kissenpfennig A, Libri V, Malissen B, Rocha B, et al. Cell-to-cell interactions and signals involved in the reconstitution of peripheral CD8 T(CM) and T(EM) cell pools. PLoS ONE. 2011;6:e17423 pubmed publisher
  706. Quere R, Andradottir S, Brun A, Zubarev R, Karlsson G, Olsson K, et al. High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event. Leukemia. 2011;25:515-26 pubmed publisher
  707. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, et al. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med. 2010;207:2561-8 pubmed publisher
  708. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  709. Echeverry A, Saijo S, Schesser K, Adkins B. Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates. Infect Immun. 2010;78:3595-608 pubmed publisher
  710. Yuan F, Li X, Lin J, Schwabe C, Bullesbach E, Rao C, et al. The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction. 2010;139:759-69 pubmed publisher
  711. Sadri N, Lu J, Badura M, Schneider R. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol. 2010;11:1 pubmed publisher
  712. Tsumiyama K, Miyazaki Y, Shiozawa S. Self-organized criticality theory of autoimmunity. PLoS ONE. 2009;4:e8382 pubmed publisher
  713. Schuhmann M, Stegner D, Berna Erro A, Bittner S, Braun A, Kleinschnitz C, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184:1536-42 pubmed publisher
  714. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  715. Getahun A, Heyman B. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand J Immunol. 2009;70:277-87 pubmed publisher
  716. Rajasagi N, Kassim S, Kollias C, Zhao X, Chervenak R, Jennings S. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J Virol. 2009;83:5256-68 pubmed publisher
  717. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  718. Kanwar N, Fayyazi A, Backofen B, Nitsche M, Dressel R, von Mollard G. Thymic alterations in mice deficient for the SNARE protein VAMP8/endobrevin. Cell Tissue Res. 2008;334:227-42 pubmed publisher
  719. Wells J, Cowled C, Farzaneh F, Noble A. Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity. J Immunol. 2008;181:3422-31 pubmed
  720. Rana S, Byrne S, MacDonald L, Chan C, Halliday G. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol. 2008;172:993-1004 pubmed publisher
  721. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  722. King S, Knorn A, Ohnmacht C, Voehringer D. Accumulation of effector CD4 T cells during type 2 immune responses is negatively regulated by Stat6. J Immunol. 2008;180:754-63 pubmed
  723. Park S, Han Y, Aleyas A, George J, Yoon H, Lee J, et al. Low-dose antigen-experienced CD4+ T cells display reduced clonal expansion but facilitate an effective memory pool in response to secondary exposure. Immunology. 2008;123:426-37 pubmed
  724. Bliss S, Bliss S, Beiting D, Alcaraz A, Appleton J. IL-10 regulates movement of intestinally derived CD4+ T cells to the liver. J Immunol. 2007;178:7974-83 pubmed
  725. Stephens G, Andersson J, Shevach E. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J Immunol. 2007;178:6901-11 pubmed
  726. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  727. Hofmann M, Brinkmann V, Zerwes H. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6:1902-10 pubmed
  728. Chen B, Deoliveira D, Cui X, Le N, Son J, Whitesides J, et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood. 2007;109:3115-23 pubmed
  729. Hintzen G, Ohl L, del Rio M, Rodriguez Barbosa J, Pabst O, Kocks J, et al. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J Immunol. 2006;177:7346-54 pubmed
  730. Hale J, Boursalian T, Turk G, Fink P. Thymic output in aged mice. Proc Natl Acad Sci U S A. 2006;103:8447-52 pubmed
  731. Hofmann M, Zerwes H. Identification of organ-specific T cell populations by analysis of multiparameter flow cytometry data using DNA-chip analysis software. Cytometry A. 2006;69:533-40 pubmed
  732. Matsuda J, Zhang Q, Ndonye R, Richardson S, Howell A, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 2006;107:2797-805 pubmed
  733. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  734. Getahun A, Hjelm F, Heyman B. IgE enhances antibody and T cell responses in vivo via CD23+ B cells. J Immunol. 2005;175:1473-82 pubmed
  735. Kelchtermans H, De Klerck B, Mitera T, Van Balen M, Bullens D, Billiau A, et al. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther. 2005;7:R402-15 pubmed
  736. Yasumi T, Katamura K, Okafuji I, Yoshioka T, Meguro T, Nishikomori R, et al. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo. J Immunol. 2005;174:1325-31 pubmed
  737. Fisson S, Darrasse Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003;198:737-46 pubmed
  738. Maris C, Miller J, Altman J, Jacob J. A transgenic mouse model genetically tags all activated CD8 T cells. J Immunol. 2003;171:2393-401 pubmed
  739. Noble A, Leggat J, Inderberg E. CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody. Immunology. 2003;109:476-86 pubmed
  740. Belnoue E, Kayibanda M, Vigario A, Deschemin J, Van Rooijen N, Viguier M, et al. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002;169:6369-75 pubmed
  741. Hsu S, Wu C, Han J, Lai M. Involvement of p38 mitogen-activated protein kinase in different stages of thymocyte development. Blood. 2003;101:970-6 pubmed
  742. Yu C, Feng M, Shih H, Lai M. Increased p300 expression inhibits glucocorticoid receptor-T-cell receptor antagonism but does not affect thymocyte positive selection. Mol Cell Biol. 2002;22:4556-66 pubmed
  743. Schmeissner P, Xie H, Smilenov L, Shu F, Marcantonio E. Integrin functions play a key role in the differentiation of thymocytes in vivo. J Immunol. 2001;167:3715-24 pubmed
  744. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  745. Van Stipdonk M, Lemmens E, Schoenberger S. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001;2:423-9 pubmed
  746. Attinger A, MacDonald H, Acha Orbea H. Lymphoid environment limits superantigen and antigen-induced T cell proliferation at high precursor frequency. Eur J Immunol. 2001;31:884-93 pubmed
  747. Ohmura K, Kawamoto H, Lu M, Ikawa T, Ozaki S, Nakao K, et al. Immature multipotent hemopoietic progenitors lacking long-term bone marrow-reconstituting activity in the aorta-gonad-mesonephros region of murine day 10 fetuses. J Immunol. 2001;166:3290-6 pubmed
  748. Broeren C, Gray G, Carreno B, June C. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J Immunol. 2000;165:6908-14 pubmed
  749. Ikawa T, Kawamoto H, Fujimoto S, Katsura Y. Commitment of common T/Natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J Exp Med. 1999;190:1617-26 pubmed
  750. Kang J, Coles M, Raulet D. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med. 1999;190:973-82 pubmed
  751. Zerrahn J, Volkmann A, Coles M, Held W, Lemonnier F, Raulet D. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A. 1999;96:11470-5 pubmed
  752. Pihlgren M, Arpin C, Walzer T, Tomkowiak M, Thomas A, Marvel J, et al. Memory CD44(int) CD8 T cells show increased proliferative responses and IFN-gamma production following antigenic challenge in vitro. Int Immunol. 1999;11:699-706 pubmed
  753. Liu L, Rich B, Inobe J, Chen W, Weiner H. Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol. 1998;10:1017-26 pubmed
  754. Kim C, Pelus L, White J, Broxmeyer H. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood. 1998;91:4434-43 pubmed
  755. Sato S, Steeber D, Jansen P, Tedder T. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J Immunol. 1997;158:4662-9 pubmed
  756. Lin K, Abraham K. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway. Int Immunol. 1997;9:291-306 pubmed
  757. Pihlgren M, Dubois P, Tomkowiak M, Sjogren T, Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med. 1996;184:2141-51 pubmed
  758. Godfrey D, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A. Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol. 1994;152:4783-92 pubmed
  759. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade P. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992;175:257-66 pubmed
  760. He Q, Lesley J, Hyman R, Ishihara K, Kincade P. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol. 1992;119:1711-9 pubmed